triamcinolone acetonide has been researched along with Central Retinal Edema, Cystoid in 757 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (0.92) | 18.2507 |
| 2000's | 383 (50.59) | 29.6817 |
| 2010's | 303 (40.03) | 24.3611 |
| 2020's | 64 (8.45) | 2.80 |
| Authors | Studies |
|---|---|
| Ciulla, TA; Hall, C; Kapik, B; Merrill, P; Singer, MA; Yeh, S | 1 |
| Baba, M; Marashi, A; Zazo, A | 1 |
| Chen, X; Zhang, L | 1 |
| Campbell, TG; Lin, ML | 1 |
| Marashi, A; Zazo, A | 1 |
| Arora, A; Gupta, M; Gupta, P; Kaur, H; Rudramurthy, SM; Singh, R | 1 |
| Abroug, N; Ben Amor, H; Khairallah, M; Khochtali, S; Nabi, W | 1 |
| Fung, S; Syed, YY | 1 |
| Albini, TA; Bhattacharyya, S; Dutta, SK; Hariprasad, SM; Harrison, D; John, D; Joseph, G; Padula, WV | 1 |
| Chang, PY; Fernandez, CC; Foster, CS; Maleki, A; Manhapra, A; Philip, AM | 1 |
| Chen, PH; Hsieh, YH; Hwang, YS; Jhou, HJ | 1 |
| Celebi, ARC; Karasu, B; Kaskal, M; Kesim, E | 1 |
| Shaddoud, I; Zaher Addeen, S | 1 |
| Arakawa, R; Masuda, T; Naito, A; Okabe, T; Otsuka, T; Suzuki, A; Takahashi, Y; Uemura, A | 1 |
| Elmahdy, AG; Khalil, MMAA; Mansour, HO; Tawfik, AMR | 1 |
| Erdogan, G; Gumus, G; Gunay, BO; Ozkaya, A | 2 |
| Fazel, F; Fazel, M; Feizi, A; Malekahmadi, M; Oliya, B; Tavakoli, M | 1 |
| Alhalabi, NM; Ali, BM; Azmeh, AM | 1 |
| Ciulla, T; Yeh, S | 1 |
| Ateeq, A; Fattah, A; Hayat, N; Majid, S; Memon, NA; Somroo, AQ | 1 |
| Minj, A; Mohanty, L; Panigrahi, PK; Thareja, J | 1 |
| Panigrahi, PK | 1 |
| Harada, Y; Hiyama, T; Kiuchi, Y; Minamoto, A; Ohara, H; Sadahide, A | 1 |
| Abdin, AD; Löw, U; Munteanu, C; Seitz, B; Wykrota, AA | 1 |
| Asmus, F; de Smet, MD; Goncerut, M; Yamamoto, R | 1 |
| Jovanović, S; Petrović, M; Petrović, N; Šarenac Vulović, T; Srećković, S; Stojadinović, I; Todorović, D | 1 |
| Chu, RL; Pannullo, NA; Sigler, EJ | 1 |
| Karasu, B | 1 |
| Cardillo, JA; Jorge, R; Messias, A; Rodrigues, MW; Scott, IU; Siqueira, RC | 1 |
| Choi, W; Han, JR; Hong, IH | 1 |
| Borkar, DS; McKay, KM; Papaliodis, GN; Sevgi, DD; Sobrin, L; Susarla, G | 1 |
| Brinkmann, R; Hirayama, K; Honda, S; Kabata, D; Kohno, T; Miura, Y; Theisen-Kunde, D; Yamamoto, M | 1 |
| Baumann, L; Karst, S; Kriechbaum, K; Mylonas, G; Reiter, G; Schmidt-Erfurth, U; Scholda, C; Schranz, M | 1 |
| Baillif, S; Biron, L; Chiffoleau, A; Couret, C; Creuzot-Garcher, C; Errera, MH; Hervouet, E; Ivan, C; Jaulin, J; Jobert, A; Kodjikian, L; Le Jumeau de Kergaradec, LM; Le Lez, ML; Poinas, A; Riche, VP; Volteau, C; Weber, M | 1 |
| Ciulla, TA; Henry, CR; Khurana, RN; Kissner, JM; Noronha, G; Shah, M; Wang, RC; Yeh, S | 1 |
| Dikmetas, O; Gelisken, F; Kuehlewein, L | 1 |
| Angkadjaja, J; Chu, J; Peng, J; Rauser, M; Sierpina, DI | 1 |
| Dhanji, S; Fung, AT | 1 |
| El Hamichi, S; Gold, AS; Graversen, VK; Latiff, A; Murray, TG | 1 |
| Ballios, BG; Mason, RH; Yan, P | 1 |
| Basak, S; Basak, SK | 1 |
| Eguchi, H; Hotta, F; Iwahashi, C; Kimura, M; Kusaka, S; Sawa, M; Uezumi, M; Yaguchi, T | 1 |
| Akiyama, H; Matsumoto, H; Mukai, R | 1 |
| Busquets, MA; Lutz, CT; Zhao, T | 1 |
| Barakat, MR; Ciulla, TA; Gonzalez, V; Hu, A; Marcus, D; Wykoff, CC; Zavaleta, E | 1 |
| Koyama, Y; Miyoshi, Y; Muraoka, Y; Nakano, Y; Osaka, R; Suzuma, K; Takasago, Y; Tsujikawa, A | 1 |
| Bae, SS; Ching, G; Covello, AT; Holland, S; Iovieno, A; McCarthy, M; Ritenour, R; Yeung, SN | 1 |
| Fazal, R; Mohan, R | 1 |
| Hsieh, YT; Hsu, WC; Yang, YH | 1 |
| Baba, T; Oshitari, T; Takatsuna, Y; Tatsumi, T; Yamamoto, S | 1 |
| Aggarwal, K; Kumawat, D; Patel, S; Samanta, R | 1 |
| Abdel-Maboud, M; Bahbah, EI; Menshawy, A; Menshawy, E; Outani, O | 1 |
| Bello, N; Chiang, A; Dunn, JP; Fineman, MS; Garg, S; Gupta, OP; Kaiser, RS; Kuley, B; Maguire, JI; Mehta, S; Obeid, A; Pancholy, M; Park, CH; Regillo, C; Sharpe, J; Spirn, MJ; Storey, PP; Vander, JF; Wibbelsman, TD; Zhang, QE | 1 |
| Barakat, MR; Ciulla, T; Dayani, P; Hall, C; Henry, CR; Khurana, RN; Rifkin, L; Shah, M; Wang, RC; Yeh, S | 1 |
| Oli, A; Waikar, S | 1 |
| Barakat, MR; Ciulla, T; Henry, CR; Kapik, B; Khurana, RN; Merrill, P; Shah, M; Suhler, E; Uchiyama, E; Wang, RC; Yeh, S | 1 |
| Noma, H; Shimura, M; Yasuda, K | 1 |
| Burgmüller, W; Findl, O; Leisser, C | 1 |
| Bosnar, D; De Salvo, G; Matić, S; Tedeschi Reiner, E; Vinković, M | 1 |
| Ciulla, TA; Henry, CR; Kapik, B; Merrill, PT; Nguyen, QD; Reddy, A | 1 |
| Dirksen, CD; Nuijts, RMMA; Schouten, JSAG; Simons, RWP; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
| Anand, N; Jones, NP; Moraji, J; Steeples, LR | 1 |
| Blériot, A; Carbonnière, C; Couret, C; Le Meur, G; Lebranchu, P; Lebreton, O; Massé, H; Weber, M | 1 |
| Jovanović, S; Petrović, N; Radotić, F; Šarenac Vulović, T; Tončić, Z; Živković, M | 1 |
| Akpolat, Ç; Aslankurt, M; Çekiç, O; Elçioğlu, M; Kurt, MM | 1 |
| Ahmadraji, A; Ghasemi, F; Karkhaneh, R; Mahmoudi, A; Riazi-Esfahani, H; Riazi-Esfahani, M; Roohipoor, R; Yaseri, M | 1 |
| Kim, SY; Kim, TK; Lee, MY; Lee, YC; Shin, HY | 1 |
| Connell, P; Fulcher, T; McAnena, L; McElnea, E; Rhatigan, M | 1 |
| Byon, IS; Choi, BS; Lee, JE; Pak, KY; Park, SW | 1 |
| E Cruz, AAV; Siqueira, RC | 1 |
| Freeman, WR; Lin, T; Muftuoglu, IK; Tsai, FF | 1 |
| Andrade, RE; Belfort, R; Branco, AC; Casella, AM; Ferreira, M; Kniggendorf, V; Maia, M; Muccioli, C; Neto, HO; Nobrega, MJ; Regatieri, CV | 1 |
| Cho, H; Hong, EH; Kang, MH; Lim, HW; Seong, M; Shin, YU | 1 |
| Lee, DY; Nam, DH; Yu, SY | 1 |
| Hafner, J; Kriechbaum, K; Kundi, M; Lammer, J; Mitsch, C; Pemp, B; Prager, SG; Schmidt-Erfurth, U; Scholda, C | 1 |
| Karst, SG; Kriechbaum, K; Kundi, M; Lammer, J; Mehta, J; Mitsch, C; Schmidt-Erfurth, U; Schober, M; Scholda, C | 1 |
| Hameed, Z; Lindfield, D; Taylor, S | 1 |
| Arevalo, JF; Couto, C; Díaz-Llopis, M; El-Haig, WM; Lasave, AF; Schlaen, A; Zeballos, DG | 1 |
| Cunefare, D; Danis, RP; Farsiu, S; Noronha, G; Vuong, VS; Willoughby, AS; Yiu, G | 2 |
| Fine, HF; Grossniklaus, HE; Prenner, JL; Reshef, ER; Roth, DB; Shah, SP | 1 |
| Călugăru, D; Călugăru, M | 1 |
| Akiyama, H; Hirato, J; Hoshino, J; Makimura, K; Todokoro, D; Yo, A | 1 |
| Saxena, H; Sharma, B; Sinha, P; Takkar, B | 1 |
| Ratra, D; Ratra, V; Shah, H | 1 |
| Artunay, O; Celebi, ARC; Erdogan, G; Eriş, E; Ozkaya, A; Perente, I; Seymen, Z; Vural, A; Vural, E | 1 |
| Januschowski, K; Wocker, L | 1 |
| Ando, T; Arai, M; Baba, T; Oshitari, T; Sato, E; Takatsuna, Y; Tatsumi, T; Yamamoto, S | 1 |
| Amon, M; Findl, O; Goslings, WRO; Henry, YP; Joosse, MV; Kohnen, T; Murta, JCN; Nagy, ZZ; Nuijts, RMMA; Rulo, AHF; Schouten, JSAG; Tassignon, MJ; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
| Arain, MA; Azhar, MN; Farooq, O; Muzaffar, W | 1 |
| Do, DV; Foster, CS; Kurup, SK; Nguyen, QD; Noronha, G; Wang, RC; Yeh, S | 1 |
| Canning, P; Klaassen, I; Schlingemann, RO; van der Wijk, AE; van Heijningen, RP; van Noorden, CJF; Vogels, IMC | 1 |
| Iida, T; Ishibashi, T; Ogura, Y; Sakamoto, T; Shimura, M; Yamada, M; Yoshimura, N | 1 |
| Brown, DM; Khurana, RN; Lampen, SIR; Noronha, G; Wykoff, CC | 1 |
| Gozawa, M; Inatani, M; Matsumura, T; Morioka, M; Takamura, Y; Yamada, Y | 1 |
| Acharya, NR; Altaweel, MM; Burke, AE; Holbrook, JT; Jabs, DA; Kempen, JH; Sugar, EA; Thorne, JE; Vitale, AT | 1 |
| Borkar, D; Goodman, J; Obeid, A; Pancholy, M; Regillo, C; Storey, PP; Su, D | 1 |
| Ali, MH; Goerlitz-Jessen, M; Grewal, DS | 1 |
| Ahnood, D; Souriti, A; Williams, GS | 1 |
| Altamirano-Vallejo, JC; Armendariz-Borunda, J; Garcia-Bañuelos, JJ; Gonzalez-De la Rosa, A; Hernandez-Gamez, AG; Navarro-Partida, J; Santos, A | 1 |
| Al-Qureshi, S; Constantinou, M; Kandasamy, R; Lim, LL; Rogers, SL; Sandhu, SS; Wickremasinghe, S | 1 |
| Abdullatif, AM; Fouad, HM; Helmy, YAH; Macky, TA; Mansour, K; Saady, AM | 1 |
| Lindholm, JM; Taipale, C; Tuuminen, R; Ylinen, P | 1 |
| Li, H; Ma, J; Meng, N; Qu, Y; Zhang, Y | 1 |
| Krásnik, V; Mrózová, L; Stefaničková, J; Strmeň, P; Vavrová, K | 1 |
| Arriola-Villalobos, P; Díaz Valle, D; Donate-López, J; García-Feijoo, J; Jiménez-Santos, M; Torres-Imaz, R; Valverde-Megías, A | 1 |
| Abu Al-Fadl, EM; Arcinue, CA; Artornsombudh, P; Foster, CS; Radwan, AE; Yang, P | 1 |
| Ober, MD; Valijan, S | 1 |
| Acar, Z; Demir, M; Dirim, B; Oba, E; Sendul, Y | 1 |
| Bolz, M; Eisenkölbl, S; Huf, W; Kiss, C; Munk, M; Sayegh, R; Schmidt-Erfurth, U; Simader, C; Sulzbacher, F | 1 |
| Bolz, M; Huf, W; Kiss, CG; Munk, MR; Roberts, P; Rückert, R; Simader, C; Sulzbacher, F | 1 |
| Bowling, B; Chen, SD; Ha, JH | 1 |
| Ackert, JM; Cohen, BZ; Friedman, AH; Sheyman, AT | 1 |
| Hutton, DW; Johnson, MW; Kim, DD; Newman-Casey, PA; Nwanyanwu, KH; Stein, JD | 1 |
| Amel, C; Bouguila, H; Malek, I; Nacef, L; Soumaya, O; Zghal, I | 1 |
| Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R | 1 |
| Amin, SR; Pulido, JS | 1 |
| Ha, HS; Kang, SW; Kim, JH; Kim, JR | 1 |
| Baser, EF; Gülhan, C; Öztürk, B; Seymenoğlu, G | 1 |
| Beck, RW; Bressler, NM; Bressler, SB; Chan, CK; Grover, S; Melia, M; Miller, DG; Qin, H | 1 |
| Han, DH; Lee, DY; Nam, DH; Sohn, HJ | 1 |
| Lin, WC; Wang, JK | 1 |
| Arévalo, FA; Arévalo, JF; Fernández, CF; García, RA; Mendoza, AJ | 1 |
| Durukan, AH; Erdurman, FC; Gokce, G; Sobaci, G | 1 |
| Alisan, S; Onder, HI; Tunc, M | 1 |
| Bakri, SJ; Larson, TA | 1 |
| Armadá, F; Cabrera, F | 1 |
| García-Campos, JM; López-Gálvez, MI | 1 |
| Figueroa, MS; Ruiz Moreno, JM | 1 |
| Funk, M; Kriechbaum, K; Kundi, M; Mylonas, G; Prager, S; Rainer, G; Schmidt-Erfurth, U; Scholda, C | 1 |
| Arai, M; Nizawa, T; Oshitari, T; Sato, E; Takatsuna, Y; Yamamoto, S | 1 |
| Boscia, F; Ciracì, L; Dayani, P; Flynn, HW; Furino, C; Mariotti, C; Sborgia, A; Tabandeh, H | 1 |
| den Hollander, AI; Hogewind, BF; Hoyng, CB; Micheal, S; Schoenmaker-Koller, FE | 1 |
| Bolz, M; Deák, GG; Lammer, J; Mylonas, G; Prager, S; Schmidt-Erfurth, U | 1 |
| Jo, YJ; Kang, SW; Kim, HK; Kim, JG; Lee, DH; Lee, JY; Park, KH; Yoon, HS; Yoon, YH | 1 |
| Jung, H; Lee, K; Sohn, J | 1 |
| Chan, CK; Silva-Garcia, R; Small, KW; Walsh, TJ | 1 |
| Acar, Z; Cinar, S; Demir, M; Guven, D; Oba, E | 1 |
| DeWilde, A; Law, C; Moyer, K | 1 |
| Jeon, S; Lee, WK | 1 |
| Fan, C; Ji, Q; Wang, Y; Xie, J; Zhao, B | 1 |
| Ciulla, TA; Harris, A; Jonescu-Cuypers, C; McIntyre, N | 1 |
| Alshareef, RA; Garg, SJ; Hsu, J; Park, C; Spirn, MJ; Vander, J | 1 |
| Choi, KS; Kang, KD; Kim, HD; Lee, SJ; Rhee, MR | 1 |
| Kakiuchi, N; Kawano, H; Otsuka, H; Sakamoto, T; Shirasawa, M; Sonoda, S; Terasaki, H; Uchino, E; Yamashita, T | 1 |
| Kim, JH; Lee, TG; Lew, YJ | 1 |
| Amini, P; Barteselli, G; Cheng, L; Ezon, IC; Freeman, WR; Nezgoda, JT | 1 |
| Akagi, T; Horii, T; Murakami, T; Nishijima, K; Ueda-Arakawa, N; Uji, A; Yoshimura, N | 1 |
| Atik, A; Guan, M; Hu, J; Hu, Y; Li, D; Li, X; Liu, Q; Tang, S; Yu, H; Yuan, L | 1 |
| Beselga, D; Campos, A; Campos, J; Mendes, S; Neves, A; Sousa, P | 1 |
| Bhayana, S; Narang, S; Sethi, NK; Sood, S | 1 |
| Chung, H; Lee, K; Park, Y; Sohn, J | 1 |
| Bandello, F; Lattanzio, R; Preziosa, C; Querques, G | 1 |
| Bleriot, A; Couret, C; Le Meur, G; Lebranchu, P; Weber, M | 1 |
| Clark, B; Craig, JE; Fitzgerald, JT; Goldberg, I; Mills, RA; Ridge, B; Saunders, L; White, AJ | 1 |
| Jain, N; Johnson, MW; Michelotti, MM | 1 |
| Dang, Y; Li, L; Liu, S; Mu, Y; Xu, Y; Zhang, C; Zhu, Y | 1 |
| Jiang, B; Li, T; Liu, X; Wang, Z; Zhou, X | 1 |
| Avci, R; Ersoy, C; Inan, UU; Kaderli, B; Kivanc, SA; Yilmaz, S; Yucel, AA | 1 |
| Arnold, JJ; Barthelmes, D; Gillies, MC; McAllister, IL; O'Day, RF; Wong, TY; Zhu, M | 1 |
| Jeng, KW; Wheatley, HM | 1 |
| Bullejos Molina, M; Cordovés Dorta, L; Losada Castillo, MJ; Lozano López, V; Mantolán Sarmiento, C; Pareja Ríos, A; Quijada Fumero, E; Serrano García, M; Virgós Aller, T | 1 |
| Jusufbegovic, D; Mugavin, MO; Schaal, S | 1 |
| Oh, J; Oh, JH | 1 |
| Bai, Y; Jin, E; Luo, L; Zhao, M | 1 |
| Ilhan, A; Yolcu, Ü | 1 |
| Hasegawa, T; Masuda, N; Ogata, N | 1 |
| Adan, A; Fonollosa, A; Mesquida, M | 1 |
| Kim, CG; Kim, JH; Kim, JW; Lee, TG; Yoo, SG | 1 |
| Chau, F; Goldstein, DA; Liu, D; Munk, MR; Rademaker, A; Ram, R; Schmidt-Erfurth, U; Setlur, V | 1 |
| Heroman, JW; Ozkok, A; Saleh, OA; Schaal, S; Sigford, DK | 1 |
| Avitabile, T; Bonfiglio, V; De Grande, V; Fallico, MR; Longo, A; Reibaldi, M; Russo, A; Uva, MG | 1 |
| Bucolo, C; Drago, V; Gagliano, C; Grosso, G | 1 |
| Anghelie, A; Chiotan, C; Cioboata, M; Cornăcel, C; Liora, R; Serban, R | 2 |
| Aref, AA; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Kim, M; Kwak, HW; Yu, SY | 1 |
| Akkaya, S; Aksoy, S; Evciman, T; Haboğlu, M; Ozkurt, YB | 1 |
| Ásgrímsdóttir, GM; Hara, K; Jóhannesson, G; Loftsson, T; Lund, SH; Ohira, A; Stefánsson, E; Tanito, M | 1 |
| Broadhead, GK; Chang, AA; Li, H; Luo, K; Zhu, M | 1 |
| Allen, LH; Li, B; Sheidow, TG | 1 |
| Shin, JY; Yu, HG | 1 |
| Sharma, A | 1 |
| Ozkok, A; Schaal, S | 1 |
| Erdol, H; Hacioglu, D; Kola, M; Turk, A | 1 |
| Bailey, C; Loewenstein, A; Massin, P; Yang, Y | 1 |
| Herrinton, LJ; Liu, L; Shorstein, NH; Waxman, MD | 1 |
| Agarwal, M; Jhala, PA; Mayor, R; Paul, L; Singh, S; Venkatesh, R | 1 |
| Atik, A; Hu, J; Hu, Y; Liu, Q; Tang, S; Yu, H; Yuan, L | 1 |
| Augustin, AJ; Cui, H; Hashad, Y; Kuppermann, BD; Lanzetta, P; Li, XY; Loewenstein, A; Whitcup, SM | 1 |
| Ciulla, LM; Ciulla, TA; Harris, A; Hussain, RM; Sink, B | 1 |
| Izumi-Nagai, K; Nagai, N; Ohta, Y; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Alam, MR; Arcinue, CA; Freeman, WR; Mendoza, NB | 1 |
| Benz, MS; Brown, DM; Chen, E; Fish, RH; Kim, RY; Li, AL; Major, JC; OʼMalley, RE; Schefler, AC; Wang, R; Wong, TP; Wykoff, CC | 1 |
| Durkin, S; Sia, DI | 1 |
| Gao, F; Liu, X; Wang, M; Zhang, M; Zhao, C | 1 |
| Ho, M; Jonas, JB; Lam, DS; Liu, DT | 1 |
| Almukhtar, T; Bressler, NM; Bressler, SB; Ferris, FL; Glassman, AR; Googe, JM; Gupta, SK; Jampol, LM; Melia, M; Wells, JA | 1 |
| Dikel, NH; Ornek, K; Yumusak, E | 1 |
| Dhawan, A; Shukla, D | 1 |
| Joe, SG; Kim, MW; Moon, H; Yang, SJ | 1 |
| Al-Qureshi, S; Constantinou, M; Kawasaki, R; Lim, LL; Morrison, JL; Rogers, S; Sandhu, SS; Wickremasinghe, SS | 1 |
| An, N; Ha, W; Hu, X; Ma, A; Zhang, S; Zhao, B | 1 |
| Chan, LW; Hsieh, YT; Hsu, WC | 1 |
| Cachulo, ML; Costa, JF; Figueira, J; Gomes, N; Marques, JP; Marques, M; Silva, R; Sousa, K | 1 |
| Dubey, AK; Harshey, KB | 1 |
| Azad, S; Takkar, B | 1 |
| Kerci, SG; Küsbeci, T; Örsel, T; Sağban, L; Uzunel, UD; Yüksel, B | 1 |
| Agarwal, R; Arora, R; Ghosh, B; Goyal, JL; Jain, P | 1 |
| Dervenis, N; Kiouras, S; Tranos, P | 1 |
| Denniston, AK; Keane, PA; Macdonald, T; Murray, PI; Sim, DA; Sreekantam, S | 1 |
| Böker, A; Davids, AM; Hager, A; Joussen, AM; Riechardt, AI; Seibel, I | 1 |
| Kim, M; Moon, J; Sagong, M | 1 |
| Arimura, S; Gozawa, M; Inatani, M; Iwasaki, K; Matsumura, T; Miyake, S; Takamura, Y; Tomomatsu, T | 1 |
| Minezaki, T; Noma, H; Shimura, M; Yasuda, K | 1 |
| Bong, A; Button, NF; Doughty, MJ; Mansfield, DC | 1 |
| Hirano, Y; Nishiyama, T; Ogura, Y; Suzuki, N; Tomiyasu, T; Uemura, A; Yasukawa, T; Yoshida, M | 1 |
| Ichio, A; Kondo, M; Sugimoto, M | 1 |
| Hsieh, YT; Tsai, MJ; Yang, CM | 1 |
| Hondur, AM; Schaal, Y; Tezel, TH | 1 |
| Chhablani, J; Dolz-Marco, R; Gallego-Pinazo, R; Paulose, R; Stewart, M | 1 |
| Brouzas, D; Georgalas, I; Georgopoulos, M; Koutsandrea, C; Malamos, P; Mylonas, G; Perisanidis, C; Sacu, S; Schmidt-Erfurth, U | 1 |
| Atchison, EA; Bakri, SJ | 1 |
| Ibraheem, RF; Iqbal, W | 1 |
| Kelkar, A; Kelkar, J; Kelkar, S; Shah, R; Vasavda, V | 1 |
| Chang, SH; Hsieh, YT; Yang, CM | 1 |
| Song, H; Wang, L | 1 |
| Chung, H; Kim, JG; Kwon, YH; Yoon, YH | 1 |
| Ikewaki, J; Imaizumi, M; Motomura, Y; Nakamuro, T; Nakatsuka, K; Ohkusu, K; Shinoda, K | 1 |
| Cheng, KC; Lin, CJ; Wu, WC | 1 |
| Bukelman, A; Hauser, D; Katz, H; Len, A; Parness-Yossifon, R; Pokroy, R; Pollack, A; Thein, R | 1 |
| Stoffelns, BM | 1 |
| Iacono, P; Parodi, MB; Ravalico, G | 1 |
| Cakir, M; Cekiç, O; Yilmaz, OF | 1 |
| Gillies, MC; Rogers, SL; Wickremasinghe, SS; Wong, TY; Zhu, M | 1 |
| Byeon, SH; Park, YS | 1 |
| Schulze-Döbold, C; Weber, M | 1 |
| Gómez-Ulla, F; Marticorena, J; Rodríguez-Blanco, M | 1 |
| Er, H | 2 |
| Domanico, D; Grenga, P; Lupo, S; Vingolo, EM | 1 |
| Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M | 1 |
| Spaide, RF | 1 |
| Hernaez-Ortega, MC; Soto-Pedre, E | 2 |
| Schachat, AP | 2 |
| Durmaz, S; Kandemir, N; Kocabora, MS | 1 |
| Dusová, J; Hejcmanová, D; Korda, V; Rencová, E; Studnicka, J | 1 |
| Jun, JH; Kim, KS; Kim, YC | 1 |
| Gillies, MC; Kifley, A; Larsson, J; Mitchell, P; Sutter, FK; Wang, JJ; Zhu, M | 1 |
| Matsushita, S; Naito, T; Sato, H; Shiota, H; Takebayashi, M | 1 |
| Breusegem, C; Stalmans, I; Van Calster, J; Vandewalle, E; Zeyen, T | 1 |
| Dinç, UA; Görgün, E; Kokame, GT; Lim, JI; Yenerel, NM; Yetik, H | 1 |
| Byeon, SH; Chung, EJ; Kim, YM; Koh, HJ; Kwon, OW; Lee, SC | 1 |
| Costa, RA; Maia, OO; Scott, IU; Takahashi, BS; Takahashi, WY | 1 |
| Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
| Ghosh, B; Goel, N; Kumar, V; Raina, UK | 1 |
| Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M; Tappeiner, C | 1 |
| Bandello, F; Lanzetta, P; Perissin, L; Veritti, D | 1 |
| Blodi, BA; Figueroa, M; Ip, MS; Jumper, JM; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Abraldes, MJ; Fernández, M; Gómez-Ulla, F | 1 |
| Jonas, JB; Rensch, F; Spandau, UH; Wickenhäuser, A | 1 |
| Chen, SD; McAllister, IL; Vijayasekaran, S; Yu, DY | 1 |
| Kimura, T; Kita, M; Nishijima, K; Oh, H; Sakamoto, A; Suzuma, K; Unoki, N; Watanabe, D; Yoshimura, N | 1 |
| Cheng, KC; Wu, HJ; Wu, WC | 1 |
| Fukushima, H; Kato, S; Toda, J | 1 |
| Adán, A; Corretger, X; Gris, O; Pelegrin, L; Torras, J | 1 |
| Ali, H; Gaston, C; Gillies, MC; Hunt, G; Simpson, JM; Zhu, M | 1 |
| Jonas, J; Rensch, F | 1 |
| Gillies, M | 1 |
| Blanco-Garavito, R; Rodriguez-Valdes, PJ | 1 |
| Baumal, CR; Blaha, GR; Duker, JS; Marx, JL; Reichel, E; Rhee, DY; Rogers, AH; Yoon, SJ | 1 |
| Aiello, LP; Beck, RW; Bressler, NM; Edwards, AR; Ferris, F; Glassman, AR; Hartnett, E; Ip, MS; Kim, JE; Kollman, C | 1 |
| Fish, GE | 1 |
| Byun, YS; Park, YH | 1 |
| Chen, WL; Chiang, CC; Lin, JM; Tsai, YY | 1 |
| Kamura, Y; Sato, Y; Shiba, T; Yagi, F | 1 |
| Chin, HS; Kang, SM; Kim, NR; Yoon, JH | 1 |
| Nakazawa, T; Nishida, K; Sakamoto, T; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Ahmadieh, H; Azarmina, M; Bijanzadeh, B; Dehghan, MH; Moradian, S; Obudi, A; Peyman, GA; Ramezani, A; Salehipour, M; Soheilian, M; Yaseri, M | 1 |
| Bakri, SJ; Edwards, AO; Pulido, JS; Risco, M | 1 |
| Cervantes-Castaneda, RA; Cordero-Coma, M; Gallagher, MJ; Klisovic, D; Larson, RJ; Lavaque, AJ; Weaver, CD; Yilmaz, T | 1 |
| Fujiwara, T; Hashizume, K; Kurosaka, D; Machida, S; Nabeshima, T | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F; Uysal, O | 2 |
| Asami, T; Ishikawa, K; Ito, Y; Kachi, S; Sugita, J; Terasaki, H; Yamakoshi, T | 1 |
| Farah, ME; Maia, M; Rodrigues, EB | 1 |
| Gutfleisch, M; Heiligenhaus, A; Heimes, B; Heinz, C; Roesel, M; Zurek-Imhoff, B | 2 |
| Horgan, N; Mashayekhi, A; Materin, MA; O'Regan, M; Salazar, PF; Shields, CL; Shields, JA | 1 |
| Hirasawa, M; Ishida, S; Noda, K; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Kim, SJ | 2 |
| Baser, E; Seymenoglu, R | 1 |
| Lorenzo-Carrero, J | 1 |
| Ghosh, B; Goel, N; Kumar, V | 1 |
| Bae, JS; Ham, IR; Lee, TG; Park, SJ | 1 |
| Zamfir, C | 1 |
| McCluskey, P; Younan, C | 1 |
| Abela-Formanek, C; Barisani-Asenbauer, T; Benesch, T; Kiss, CG; Maca, SM; Sacu, SG | 1 |
| Detorakis, ET; Pallikaris, IG; Panteleontidis, V; Papadaki, T; Tsilimbaris, MK | 1 |
| Antoszyk, A; Blodi, BA; Elman, M; Figueroa, M; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Antoszyk, AN; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Hou, J; Jiang, YR; Jonas, JB; Li, XX; Tao, Y | 1 |
| Chan, CK; Lai, TY; Lam, DS; Lee, VY; Leung, GM; Li, KK; Li, PS; Liu, DT; Mohamed, S | 1 |
| Agarwal, M; Chaudhary, SP; Narula, R; Shroff, C | 1 |
| Guthoff, R; Hennemann, K; Meigen, T; Schrader, W | 2 |
| Apte, RS | 1 |
| Blodi, BA; Chan, CK; Fisher, M; Gonzalez, VH; Ip, MS; Oden, NL; Scott, IU; Singerman, LJ; Tolentino, M; VanVeldhuisen, PC | 2 |
| Fujihara, M; Kumagai, K; Kurimoto, Y; Oishi, A; Takahashi, M | 1 |
| Katz, D; Lavergne, V; Rudnisky, CJ | 1 |
| Lee, HY; Lee, SY; Park, JS | 1 |
| Ali, H; Gaston, C; Gillies, MC; Hunt, G; Simpson, JM; Sutter, F; Zhu, M | 1 |
| Chen, KJ; Cheng, KC; Wu, WC | 1 |
| Cohen, SY; Nghiem-Buffet, S | 1 |
| Blodi, BA; Domalpally, A; Ip, MS; Lauer, AK; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Costa, RA; Folgosa, MS; Jorge, R; Messias, A; Scott, IU; Takata, C | 1 |
| Chen, SH; Shah, AS | 1 |
| Gao, L; Hou, J; Jiang, YR; Li, XX; Tao, Y | 1 |
| Liu, K; Xu, X; Yang, XL | 1 |
| López-Gálvez, MI; Pastor-Jimeno, JC | 1 |
| Gillies, M; Kuo, CH; McCluskey, P | 1 |
| Beck, RW; Bressler, NM; Edwards, AR; Flaxel, CJ; Glassman, AR; Ip, MS; Kollman, C; Kuppermann, BD; Stone, TW | 1 |
| Abud, MB; Avila, M; Frantz, KA; Isaac, DL; Rassi, AR | 1 |
| Arnold, JJ; Gillies, MC; Louis, D; McAllister, IL; Wong, TY; Wong, W; Zhu, M | 2 |
| Kim, JY; Park, SP | 1 |
| Alimahmoudi, A; Dianat, S; Faghihi, H; Lashay, A; Mirshahi, A; Shenazandi, H | 1 |
| Aiello, LP; Beck, RW; Bressler, NM; Davis, MD; Edwards, AR; Ferris, F; Glassman, AR; Ip, MS; Miller, KM | 1 |
| Freeman, WR; Oster, SF; Shah, AM | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Agostini, H; Böhringer, D; Feltgen, N; Lubrich, B; Ness, T | 1 |
| Abe, S; Kirii, E; Nakano, S; Yamamoto, T; Yamashita, H | 1 |
| Folgosa, MS; Jorge, R; Lucena, DR; Lucena, LR; Messias, A; Scott, IU; Takata, C | 1 |
| Byun, YJ; Koh, HJ; Lee, SC; Roh, MI | 1 |
| Breedijk, MA; Duijvesz, D; Steijns, D; van der Heijden, GJ | 1 |
| Keating, D; Muqit, MM; Murdoch, JR; Saidkasimova, S | 1 |
| Kiavash, V; Peyman, GA; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Yaseri, M | 2 |
| Hu, YJ | 1 |
| Beck, RW; Ferris, FL; Glassman, AR; Miller, KM | 1 |
| Aiello, LP; Beck, RW; Bressler, NM; Bressler, SB; Edwards, AR; Elman, MJ; Ferris, FL; Friedman, SM; Glassman, AR; Miller, KM; Scott, IU; Stockdale, CR; Sun, JK | 1 |
| Dhanapala, M; Gilhotra, J; Gray, T; Simon, S | 1 |
| Ishibashi, T; Kunikata, H; Nakazawa, T; Nishida, K; Shimura, M; Sonoda, KH; Yoshimura, T | 1 |
| Ahmadabadi, HF; Beheshtnejad, H; Mirshahi, A; Mohammadi, M | 1 |
| Kamei, M; Matsumura, N; Nishida, K; Sakaguchi, H; Sayanagi, K; Tano, Y; Tsujikawa, M; Yamamoto, T | 1 |
| Gaston, C; Gillies, MC; Islam, FM; Larsson, J; Pasadhika, S; Wong, TY; Zhu, M | 1 |
| Wong, IY | 1 |
| Carstocea, B; Cerbulescu, B; Dinita, M; Malaeanu, R; Radocea, R; Taina, AL | 1 |
| Bui, A; Chan, C; Freund, KB; Jain, A; Kertes, PJ; Sarraf, D; Vyas, N | 1 |
| Grabska-Liberek, I; Jamrozy-Witkowska, A; Kowalska, K; Oficjalska-Młyńczak, J | 1 |
| Göbel, W; Guthoff, R; Hennemann, K; Meigen, T; Schrader, W | 1 |
| Ackermann, H; Al-Sarireh, F; Koch, FH; Koss, MJ; Naser, H; Sener, A; Singh, P | 1 |
| Cordero-Coma, M; Gallagher, MJ; Teasley, LA; Yilmaz, T | 1 |
| Chen, HS; Chuang, LH; Ku, WC; Lai, CC; Wang, NK; Yeung, L | 1 |
| Behar-Cohen, F; Torriglia, A; Valamanesh, F | 1 |
| Gelisken, F; Ziemssen, F | 1 |
| Hayashi, H; Kameda, T; Kita, M; Nishijima, K; Oh, H; Sakamoto, A; Unoki, N; Yoshimura, N | 1 |
| Goyal, S; Lavalley, M; Subramanian, ML | 1 |
| Akova, YA; Ugurbas, SC | 1 |
| Bandello, F; Battaglia Parodi, M; Lanzetta, P; Loewenstein, A; Massin, P; Menchini, F; Veritti, D | 1 |
| Horii, T; Murakami, T; Nishijima, K; Ota, M; Sakamoto, A; Takayama, K; Yoshimura, N | 1 |
| Baltă, F; Davidescu, L; Mocanu, C; Olaru, A; Puşcaşu, CR | 1 |
| Chang, S; Del Priore, LV; Fine, HF; Gelman, SK; Hwang, JC | 1 |
| Altaweel, MM; Blodi, BA; Domalpally, A; Elledge, J; Ip, MS; Kim, JE; Oden, NL; Scott, IU; Van Veldhuisen, PC; Warren, K | 1 |
| Gale, J; Hollands, H; Hollands, S; Seif, G | 1 |
| Bae, JH; Lee, CS; Lee, SC | 1 |
| Alagöz, N; Bozkurt, E; Cakır, M; Cekiç, O; Faruk Yılmaz, O; Yazıcı, AT | 1 |
| Blodi, BA; Cohen, G; Hartnett, ME; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
| Cordero-Coma, M; Gallagher, MJ; Lavaque, AJ; Padula, WV; Yilmaz, T | 1 |
| Beck, RW; Bressler, NM; Chew, EY; Ferris, FL; Fish, GE; Glassman, AR; Kinyoun, JL | 1 |
| Buyukyildiz, HZ; Gulkilik, G; Kumcuoglu, YZ | 1 |
| Arimura, N; Sakamoto, T; Shimura, M; Sonoda, Y | 1 |
| Akinci, A; Altınsoy, A; Muftuoglu, O; Ozkılıc, E | 1 |
| Aref, AA; Scott, IU | 2 |
| Chung, H; Kim, HC; Shin, HJ | 1 |
| Liu, W; Shi, A; Shi, X; Wang, Y | 1 |
| Ehlers, JP; Fekrat, S | 1 |
| Ding, X; Hu, X; Li, J; Pan, J; Tang, S; Yu, S | 1 |
| Böhm, MR; Uhlig, CE | 1 |
| Fujioka, C; Furuta, M; Matsubara, H; Matsumoto, T; Matsuura, M; Sasoh, M; Sugimoto, M; Uji, Y; Wada, H | 1 |
| Li, MH; Li, X; Su, XN; Wang, HY; Wang, YS; Zhang, ZF | 1 |
| Avci, R; Gelisken, O; Kaderli, B; Yalcinbayir, O | 1 |
| Aiello, LP; Antoszyk, A; Beck, RW; Bressler, NM; Bressler, SB; Brucker, AJ; Ferris, FL; Glassman, AR; Googe, J; Marcus, D; Qin, H; Stockdale, CR | 1 |
| Fung, AE; Hung, D; Lim, JI; Wieland, M; Wong, V | 1 |
| Chiroli, V; Impagnatiello, F; Khoobehi, B; Miglietta, D; Ongini, E; Ronchetti, D; Thompson, H | 1 |
| Díaz-Llopis, M; Gallego-Pinazo, R; Martínez-Castillo, S | 1 |
| Bijanzadeh, B; Mirdehghan, SA; Obudi, A; Ramezani, A; Soheilian, M; Yaseri, M | 1 |
| Beck, RW; Bressler, NM; Elman, MJ; Ferris, FL; Friedman, SM; Glassman, AR; Qin, H; Scott, IU; Stockdale, CR; Sun, JK | 1 |
| Arevalo, JF; Berrocal, MH; Cardillo, JA; Farah, ME; Maia, M; Penha, FM; Rodriguez, FJ; Wu, L | 1 |
| Bringmann, A; Drechsler, F; Hollborn, M; Köferl, P; Kohen, L; Rehak, M; Wiedemann, P | 1 |
| Altun, S; Gundogan, FC; Tas, A | 1 |
| Bidot, ML; Bidot, S; Bron, A; Creuzot-Garcher, C; Malvitte, L | 1 |
| Clark, D; Qureshi, F | 1 |
| Dunn, JP; Galor, A; Jabs, DA; Leder, HA; Thorne, JE | 1 |
| Bourcier, T; Gaucher, D; Letsch, J; Saleh, M; Speeg-Schatz, C | 1 |
| Lee, JJ; Lee, SJ; Song, JH | 1 |
| Sawada, K | 1 |
| Elbendary, AM; Shahin, MM | 1 |
| Han, DH; Kim, IT; Kim, KH; Lee, DY; Nam, DH; Oh, IK; Sohn, HJ | 1 |
| Cordero-Coma, M; Federici, TJ; Yilmaz, T | 1 |
| Augustin, A; Augustin, C; Barca, F; Bartolo, ED; Cresti, F; Ebert, FG; Rizzo, S | 1 |
| Hirano, Y; Nakazawa, T; Ogura, Y; Sakamoto, T; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Krummenauer, F; Lösche, CC; Schmidt, B | 1 |
| Arimura, N; Doi, N; Ishibashi, T; Sakamoto, T; Sonoda, Y; Uchino, E; Yasuda, M; Yonemoto, K | 1 |
| Bozkurt, E; Demir, S; Demirok, A; Kara, N; Yazici, AT; Yilmaz, OF; Yuksel, K | 1 |
| Chung, H; Kim, HC; Lee, SH; Shin, HJ | 1 |
| Bayraktar, ZM; Durukan, HA; Erdurman, C; Ozge, G; Sobaci, G | 1 |
| Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B | 1 |
| Do, HH; Elgohary, M; Habot-Wilner, Z; Lightman, S; McCluskey, P; Sallam, A; Taylor, SR | 1 |
| Bhaduri, G; Dutta, J; Ghosh, S; Mukhopadhyay, S | 1 |
| Lee, HK; Lim, JW; Shin, MC | 1 |
| Daly, MK; Freddo, T; McKnight, CJ; Shukla, AN | 1 |
| Fonollá Gil, M; García Alonso, A; García Fernández, M; Rodríguez Villa, S | 1 |
| Hashim, AA; Tyagi, P | 1 |
| Feucht, N; Kook, PE; Lohmann, CP; Maier, M; Schuster, T | 1 |
| Higashiyama, T; Kakinoki, M; Kawamura, H; Ohji, M; Sawada, O; Sawada, T | 1 |
| Chae, JB; Joe, SG; Kim, JG; Lee, JY; Yang, SJ; Yoon, YH | 1 |
| Chung, SE; Kang, SW; Kim, SJ; Kim, SM; Kim, YT | 1 |
| Garfami, KH; Peyman, GA; Ramezani, A; Soheilian, M; Yaseri, M | 1 |
| Ahn, JH; Lee, JE; Oum, BS; Park, HJ | 1 |
| Cho, HY; Lee, WJ | 1 |
| Funatsu, H; Mimura, T; Noma, H; Shimada, K | 3 |
| Fraser-Bell, S; Gillies, M; Salem, W | 1 |
| Bianciotto, CG; Materin, MA; Shields, CL; Wu, C | 1 |
| Cheung, CS; Devenyi, RG; Kertes, PJ; Lam, WC; Lui, A; Wong, AW | 1 |
| Asteriades, S; Pavesio, CE; Tranos, PG; Tsaousis, KT; Vakalis, AN | 1 |
| Eguchi, H; Katome, T; Mitamura, Y; Nagasawa, T; Naito, T | 1 |
| Apte, RS; Dewan, V; Edler, J; Kymes, S; Lambert, D | 1 |
| Cucu, B; Enache, V; Manole, C; Zemba, M | 1 |
| Banifatemi, M; Rahimi, M; Shahrzad, SS | 1 |
| Bi, S; Cui, H; Qi, HP; Wei, SQ; Zhao, JB | 1 |
| Kaplan, HJ; Sonmez, K; Tezel, TH | 1 |
| Duncombe, A; Genevois, O; Le Moigne, O; Muraine, M; Portmann, A | 1 |
| Sanisoglu, H; Sevim, MS; Turkyilmaz, K | 1 |
| Blodi, BA; Ip, MS; Scott, IU; VanVeldhuisen, PC; Wahle, AE; Weinberg, DV | 1 |
| Chen, L; Geng, J; Liu, L; Wu, X; Yuan, Z | 1 |
| Bi, C; Chen, F; Wang, H; Wei, Y; Yang, X; Zu, Z | 1 |
| Funatsu, H; Mimura, T; Noma, H | 1 |
| Cho, HY; Chung, SE; Kang, SW; Kim, YT; Lee, SW | 1 |
| Smiddy, WE | 1 |
| Basu, S; Haque, MN; Kesarwani, S; Padhi, TR | 1 |
| Nentwich, MM; Ulbig, MW | 1 |
| Amiran, MD; Ishay, A; Lang, Y; Luboshitzky, R; Sartani, G; Yeung, SN | 1 |
| Allam, SS; Batchelet, AR; Compton, MW; Ghazi, NG; Patrie, J; Salti, HI; Scruggs, RT | 1 |
| Chen, FH; Wang, HZ; Wang, RS; Wei, Y; Yang, XG | 1 |
| Do, HH; Habot-Wilner, Z; Lightman, S; McCluskey, P; Pacheco, PA; Sallam, A | 1 |
| Alakuş, MF; Işcan, Y; Oner, V; Taş, M; Türkcü, FM; Yüksel, K | 1 |
| Kasbekar, S; Kumar, BV; Prasad, S | 1 |
| Atili, A; Baraki, H; Feltgen, N; Geck, U; Hoerauf, H; Pustolla, N | 1 |
| Degenring, R; Jonas, JB | 1 |
| Ip, MS; Kumar, KS | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I | 5 |
| Degenring, R; Jonas, JB; Kreissig, I | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I; Söfker, A | 1 |
| Canakis, C; Conway, MD; Livir-Rallatos, C; Peyman, GA | 1 |
| Audren, F; Benhamou, N; Gaudric, A; Haouchine, B; Massin, P; Tadayoni, R | 1 |
| Benz, MS; Dubovy, SR; Eifrig, CW; Katz, RS; Murray, TG | 1 |
| Bakri, SJ; Beer, PM; Liu, W; Miller, M; Peters, GB; Singh, RJ | 1 |
| Lang, GE | 2 |
| Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 3 |
| Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU | 1 |
| Chaudhry, NA; Chieh, J; Green, SN; Roth, DB; Spirn, MJ; Yarian, DL | 1 |
| Fekrat, S; Jaffe, GJ; Park, CH | 1 |
| Flynn, HW; Rosenfeld, PJ; Scott, IU | 1 |
| Gillies, MC; Sutter, FK | 1 |
| Belmont, JB; Martidis, A; Nelson, ML; Regillo, CD; Sivalingam, A; Tennant, MT | 1 |
| Karacorlu, M; Karacorlu, S; Ozdemir, H | 2 |
| Giannakopoulos, N; Halkiadakis, I; Koutsandrea, C; Markomichelakis, NN; Pantelia, E | 1 |
| Thall, EH | 1 |
| Chen, SD; Frith, P; Lochhead, J; Patel, CK | 1 |
| Ohguro, N; Okada, AA; Tano, Y | 1 |
| Jonas, JB | 2 |
| Kwong, YY; Lai, WW; Lam, DS | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Caulin, C; Erginay, A; Gaudric, A; Haouchine, B; Massin, P | 1 |
| Enaida, H; Ishibashi, T; Kubota, T; Miyazaki, M; Nakamura, T; Noda, Y; Sakamoto, T; Sonoda, KH; Ueno, A; Yokoyama, M | 1 |
| Inoue, M; Kitamura, S; Nagai, N; Oguchi, Y; Shinoda, H; Shinoda, K | 1 |
| Dogra, MR; Gupta, A; Gupta, V; Kaushik, S; Singh, R | 1 |
| Egbert, P; Engelman, CJ; Palmer, JD | 1 |
| Yamamoto, T | 2 |
| Degenring, RF; Jonas, JB; Kamppeter, BA | 1 |
| Farah, ME; Sallum, JM; Saraiva, VS | 1 |
| Degenring, RF; Jonas, JB | 1 |
| Baatz, H; Mirshahi, A; Scharioth, GB | 1 |
| Klais, CM; Spaide, RF | 2 |
| Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I | 1 |
| Bartholomew, D; Horgan, SE; Sherefat, H; Wong, R | 1 |
| Barker, D; Kuhn, F | 1 |
| Roh, M; Savage, H | 1 |
| Chan, CK; Chan, WM; Cheung, BT; Lam, DS; Lee, VY; Yuen, CY | 1 |
| Csaky, KG; Gravlin, L; Kim, H; Robinson, MR; Rodriguez-Coleman, H; Srivastava, S; Yuan, P | 1 |
| Detry-Morel, M; Escarmelle, A; Hermans, I | 1 |
| Ahmad, SI; Allingham, RR; Challa, P; Herndon, LW; Lee, PP; Singh, IP; Yeh, D | 1 |
| Burumcek, E; Karacorlu, M; Karacorlu, SA; Mudun, B; Ozdemir, H | 1 |
| Alacali, N; Karacorlu, M; Karacorlu, S; Ozdemir, H | 1 |
| Altaweel, MM; Blodi, BA; Gangnon, RE; Gottlieb, JL; Ip, MS; Kahana, A; Puliafito, CA; Scott, IU | 1 |
| Allam, S; Bashshur, ZF; Haddad, RS; Jurdi, FA; Ma'luf, RN; Noureddin, BN | 1 |
| Alacali, N; Burumcek, E; Karacorlu, M; Karacorlu, S; Mudun, B; Ozdemir, H | 1 |
| Barile, G; Chang, S; Ciardella, AP; Klancnik, J; Langton, K; Schiff, W | 1 |
| Das, T; Pathengay, A; Pilli, S | 1 |
| Bakri, SJ; Beer, PM; Falk, NS; Shah, A | 1 |
| Lim, CS; Negi, AK; Owen-Armstrong, K; Vernon, SA | 1 |
| Lee, WF; Yang, CM | 1 |
| Flynn, HW; Moshfeghi, AA; Puliafito, CA; Scott, IU | 1 |
| Chan, CK; Chan, WM; Fan, DS; Lai, TY; Lai, WW; Lam, DS; Lee, VY; Mohamed, S | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Caulin, C; Erginay, A; Gaudric, A; Haouchine, B; Massin, P; Tod, M | 1 |
| Agrawal, J; Agrawal, S; Agrawal, TP | 2 |
| Gillies, MC; Simpson, JM; Sutter, FK | 1 |
| Chen, SD; Lochhead, J; Patel, CK | 1 |
| Klemperer, I; Levy, J; Lifshitz, T; Tessler, Z | 1 |
| Chan, CK; Chan, WM; Fan, DS; Lam, DS; Li, KK; Tang, EW | 1 |
| Islam, MS; Negi, A; Vernon, SA | 2 |
| Asano, Y; Hida, T; Hirakata, A; Kojima, E; Morimura, Y; Okada, AA; Wakabayashi, T | 1 |
| Krepler, K; Sacu, S; Wagner, J; Wedrich, A | 1 |
| Brooks, HL; Caballero, S; Grant, MB; Harrison, JK; Newell, CK; Scott, EW; Segal, MS; Steinmetz, RL; Watson, D | 1 |
| Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I | 1 |
| Harder, B; Jonas, JB; Kamppeter, BA | 1 |
| Castro, MR; Edelman, JL; Lutz, D | 1 |
| Bakri, SJ; Beer, PM | 1 |
| Flynn, HW; Scott, IU | 1 |
| Haamann, P; Larsen, M; Sørensen, TL; Villumsen, J | 1 |
| Ergun, E; Krepler, K; Richter-Müksch, S; Sacu, S; Stur, M; Wagner, J; Wedrich, A | 2 |
| Gotoh, T; Iijima, H; Imai, M; Imasawa, M; Ohshiro, T | 1 |
| Jarin, RR; Lim, TH; Teoh, SC | 1 |
| Dogan, H; Erkilic, K; Evereklioglu, C; Ozkiris, A | 1 |
| Bakri, SJ; Kaiser, PK | 1 |
| Heatley, G; Jonas, J; Spaide, R; Varma, R | 1 |
| Imai, H; Kusuhara, S; Nakanishi, Y; Negi, A; Teraoka Escaño, MF; Tsukahara, Y; Yamamoto, H | 1 |
| Gillies, MC; Larsson, J; Sutter, F; Zhu, M | 1 |
| O'Donnell, A; Williamson, TH | 1 |
| Kaya, M; Onder, HI; Tunc, M | 1 |
| Eandi, CM; Freund, KB; Klais, CM; Yannuzzi, LA | 1 |
| Hayashi, H; Hayashi, K | 1 |
| Kaiser, PK | 1 |
| Cannon, PS; Habib, MS; Steel, DH | 1 |
| Kim, HK; Park, HY; Yi, K | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H | 1 |
| Hori, S | 1 |
| Kitano, S | 1 |
| Chan, A; Duker, JS | 1 |
| Belfort, R; Cardillo, JA; Costa, RA; Farah, ME; Kuppermann, BD; Melo, LA; Skaf, M; Souza-Filho, AA | 1 |
| Cleary, PE; Cullinane, A; Gibran, SK; Jungkim, S | 1 |
| Fukushima, M; Inumaru, J; Koga, T; Mawatari, Y; Tanihara, H | 1 |
| Vernon, SA | 1 |
| Derse, M; Jonas, JB; Papoulis, C; Schmitz-Valckenberg, P; Spandau, UH | 1 |
| Branley, M; Shah, A | 1 |
| Lai, WW; Lam, DS; Law, RW | 1 |
| Avci, R; Kaderli, B | 1 |
| Das-Bhaumik, RG; Jones, NP | 1 |
| Fong, KC; Horgan, SE; Ziahosseini, K | 1 |
| Awai, N; Fukushima, M; Hirata, A; Inomata, Y; Kawaji, T; Takano, A; Tanihara, H | 1 |
| Fernando, AI; Pandit, JC | 1 |
| Doi, N; Nakao, K; Sakamoto, T; Uemura, A | 1 |
| Reichle, ML | 1 |
| Kok, H; Lau, C; Lightman, S; Maycock, N; McCluskey, P | 1 |
| Barbosa, JC; Bonini-Filho, MA; Calucci, D; Cardillo, JA; Costa, RA; Jorge, R | 1 |
| Angunawela, RI; Antcliffe, RJ; Graham, EM; Heatley, CJ; Spalton, DJ; Stanford, MR; Williamson, TH | 1 |
| Angerman, S; Kytö, JP; Lumiste, E; Paloheimo, M; Summanen, PA | 1 |
| Hvarfner, C; Larsson, J; Skarin, A | 1 |
| Attia, S; Ben Yahia, S; Jenzri, S; Khairallah, M; Ladjimi, A; Messaoud, R; Zaouali, S; Zeghidi, H | 1 |
| Akkoyun, I; Degenring, RF; Jonas, JB; Kreissig, I; Martus, P | 1 |
| Avitabile, T; Longo, A; Reibaldi, A | 1 |
| Fukushima, M; Hirata, A; Inumaru, J; Koga, T; Mawatari, Y; Tanihara, H | 1 |
| Farah, T; Salti, H | 1 |
| Romano, M; Romano, MR; Valldeperas, X; Wong, D | 1 |
| Gaudric, A; Giraud, C; Girmens, JF; Krivosic, V; Paques, M; Sahel, J | 1 |
| Aloni, E; Bukelman, A; Hauser, D; Katz, H; Len, A; Parnes, R; Pokroy, R; Pollack, A; Thein, R | 1 |
| Jonas, JB; Kamppeter, B | 1 |
| Berreen, J; Margolis, TP; Saidel, MA | 1 |
| Hung, PT; Lin, JM; Tsai, YY | 1 |
| Ugarte, M; Williamson, TH | 1 |
| Morescalchi, F; Staurenghi, G; Viola, F | 1 |
| Inoue, M; Kawaguchi, N; Shinoda, K; Sugimura, E; Sugisaka, E; Tsubota, K | 1 |
| Bashshur, ZF; Jurdi, FA; Noureddin, BN; Schakal, A; Zein, WM | 1 |
| Enaida, H; Hata, Y; Ishibashi, T; Kubota, T; Miyazaki, M; Mochizuki, Y; Murata, T; Sakamoto, T; Ueno, A; Yoshiyama, K | 1 |
| Gonzales, CR; Quiram, PA; Schwartz, SD | 1 |
| Harder, B; Jonas, JB; Kreissig, I; Spandau, UH | 1 |
| Aggermann, T; Binder, S; Brunner, S; Stolba, U | 1 |
| Chen, SD; Lochhead, J; Patel, CK; Sundaram, V | 1 |
| Harder, B; Jonas, JB; Kamppeter, BA; Sauder, G; Spandau, UH; Vossmerbaeumer, U | 2 |
| Cheng, L; Freeman, WR; Kosobucki, BR | 1 |
| Barak, A; Goldstein, M; Loewenstein, A; Regenbogen, M | 1 |
| Averbukh, E; Banin, E | 1 |
| Thompson, JT | 1 |
| Ho, TC; Lai, WW; Lam, DS | 1 |
| Muftuoglu, G; Sarici, A | 1 |
| Hu, J; Katz, BJ; Turner, MJ; Wang, C; Zhang, K | 1 |
| de Vries, P; Rothova, A; van Kooij, B | 1 |
| Eandi, CM; Freund, KB; Goldberg, DE; Klais, CM; Ober, MD; Sorenson, JA; Yannuzzi, LA | 1 |
| Baek, S; Huh, K; Oh, IK; Oh, J | 1 |
| Clay, EL; Hollander, DA; Sidikaro, Y | 1 |
| Browning, AC; Negi, AK; Vernon, SA | 1 |
| Hamam, R; Khairallah, N; Khoury, J; Salti, HI | 1 |
| Chiu, YT; Hung, PT; Lin, JM; Tsai, YY | 2 |
| Cho, HY; Kang, SW; Kim, JI; Sa, HS | 1 |
| Assia, E; Ferencz, JR; Gilady, G; Shulman, S; Ton, Y | 1 |
| Gelston, CD; Mandava, N; Olson, JL | 1 |
| Erol, N; Topbas, S | 1 |
| Dhir, L; Prasad, SD | 1 |
| Harun, S; Kumar, BV; Prasad, S | 1 |
| Chan, CK; Lai, TY; Lam, DS; Mohamed, S; Shanmugam, MP; Tsang, CW | 1 |
| Konstantopoulos, A; Luff, AJ; Newsom, RS; Williams, CP | 1 |
| Ito, T; Nozaki, M; Ogura, Y | 1 |
| Kim, R; Vedantham, V | 1 |
| Pathai, S | 1 |
| Erdinç, A; Ozdek, SC | 1 |
| Ali, H; Gillies, MC; Larsson, J; Simpson, JM; Sutter, FK; Zhu, M | 1 |
| Alhalel, A; Desatnik, H; Glovinsky, J; Habot-Wilner, Z; Moisseiev, J; Moroz, I | 1 |
| Goldstein, M; Loewenstein, A | 1 |
| Kasten-Aker, AG; Nickerson, MM; Pizzimenti, CE; Pizzimenti, JJ | 1 |
| Cheng, KC; Wu, WC | 1 |
| Au Eong, KG; Beatty, S; Kwok, AK; Sangtam, T; Tan, CS | 1 |
| Ozkiriş, A | 1 |
| Browning, DJ; Fraser, CM; Powers, ME | 1 |
| Byon, IS; Jea, SY; Oum, BS | 1 |
| Abhas, Z; Garg, S; Venkatesh, P; Vohra, R | 1 |
| Karia, N; Patel, PJ; Zaheer, I | 1 |
| Aslan, O; Batman, C; Berker, N; Elgin, U; Ozkan, SS | 1 |
| Longo, A | 1 |
| González Barcia, M; Lorenzo Carrero, J; Pérez Flores, I | 2 |
| Bobbili, RB; Mathai, A | 1 |
| Ho, TC; Lai, WW | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Conrath, J; Erginay, A; Gaudric, A; Haouchine, B; Massin, P | 1 |
| Barton, K; Heatley, CJ; Lim, KS; Siriwardena, D | 1 |
| Chan, CK; Chan, WM; Lai, TY; Lam, DS; Li, KK; Li, PS; Mohamed, S; Shanmugam, MP; Tsang, CW | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Erginay, A; Gaudric, A; Haouchine, B; Lecleire-Collet, A; Massin, P | 1 |
| Gutfleisch, M; Heiligenhaus, A; Lommatzsch, A; Mingels, A; Pauleikhoff, D; Spital, G | 1 |
| Konstantopoulos, A; Luff, AJ; Williams, CP | 1 |
| Aslam, S; Davies, N; Malik, N | 1 |
| Berrocal, AM; Flynn, HW; Gregori, G; Gregori, NZ; Lee, JE; Mavrofrides, EC; Murray, TG; Puliafito, CA; Rosenfeld, PJ; Scott, IU; Smiddy, WE | 1 |
| Ai, E; Fu, AD; Goff, MJ; Johnson, RN; Jumper, JM; McDonald, HR; Yang, SS | 1 |
| Nakazawa, T; Nishida, K; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Lightman, S; McCluskey, P; Sivaprasad, S | 1 |
| Atta, HR; Cauchi, PA; Sarros, M | 1 |
| Arora, A; Rishi, P; Sharma, T | 1 |
| Dubey, AK | 1 |
| Ho, TC | 1 |
| Brasil, OF; Galor, A; Kaiser, PK; Lowder, CY; Sears, JE; Smith, SD | 1 |
| Apostolopoulos, M; Brouzas, D; Loukianou, E; Moschos, M; Moschos, MM | 1 |
| Chen, C; Du, L; Xing, Y | 1 |
| Cardillo, JA; Oliveira, AG; Souza-Filho, AA | 1 |
| Charles, SJ; Jain, A; Vishwanath, MR | 1 |
| Gunnarsdóttir, SG; Gunnlaugsdóttir, E; Oehman, DO; Stefánsson, E | 1 |
| Bringmann, A; Iandiev, I; Pannicke, T; Reichenbach, A; Wiedemann, P; Wurm, A | 1 |
| Lang, Y; Leibu, R; Miller, B; Perlman, I; Shoham, N | 1 |
| Atmaca, LS; Ozdemir, O; Yalçindağ, FN | 1 |
| La Cour, M; Larsen, M; Lund-Andersen, H; Sander, B; Vinten, M | 1 |
| Adams, D; Baird, JH; Bernstein, PS; Hu, J; Li, C; Payne, M; Teske, MP; Wang, C; Yang, Z; Zhang, K | 1 |
| Kita, M; Miyamoto, K; Tsujikawa, A; Yamaike, N; Yoshimura, N | 1 |
| Azen, SP; Freeman, WR; Kayicioglu, OO; Kozak, I; LaBree, LD; Morrison, VL | 1 |
| Engin, G; Gulkilik, G; Kucuksahin, H; Selim Kocabora, M; Taskapili, M; Yilmazli, C | 1 |
| Apostolopoulos, M; Brouzas, D; Koutsandrea, C; Loukianou, E; Moschos, M; Moschos, MM | 1 |
| Enaida, H; Hata, Y; Hisatomi, T; Ishibashi, T; Matsumoto, H; Ogino, N; Sakamoto, T; Ueno, A; Yamanaka, I | 1 |
| Choi, YJ; Huh, K; Oh, IK; Oh, JR | 1 |
| Avci, R; Gelisken, O; Kaderli, B; Yucel, AA | 1 |
| Iida, T | 1 |
| Ataka, S; Kurita, K; Shiraki, K; Tayeya, K; Wada, S | 1 |
| Chu, YK; Chung, EJ; Koh, HJ; Kwon, OW; Lee, JH | 1 |
| Batioğlu, F; Celik, S; Ozmert, E; Parmak, N | 1 |
| Audren, F; Gaucher, D; Haouchine, B; Lecleire-Collet, A; Massin, P; Offret, O | 1 |
| Chan, CK; Lai, TY; Lam, DS; Lee, VY; Li, KK; Li, PS; Liu, DT; Mohamed, S; Shanmugam, MP | 1 |
| Ahn, JK; Chung, H; Heo, JW; Oh, JY; Seo, JH | 1 |
| Choi, KS; Chung, JK; Lim, SH | 1 |
| Kita, H; Sakamoto, T; Uemura, A; Yamashita, T | 1 |
| Inatani, M; Iwao, K; Kawaji, T; Koga, T; Mawatari, Y; Tanihara, H | 1 |
| Altintaş, O; Bardak, Y; Cekiç, O; Demirkol, A; Ekim, MM; Oyar, O; Tiğ, SU; Yeşildağ, A | 1 |
| Miyake, T; Mizuno, S; Morita, H; Nishiwaki, A; Ogura, Y | 1 |
| Mian, SI; Saxe, SJ; Shtein, RM; Stahl, RM | 1 |
| Chalioulias, K; Tsaloumas, M | 1 |
| Aiello, LP; Antoszyk, A; Beck, R; Bressler, N; Browning, D; Chew, E; Danis, R; Fan, J; Flaxel, C; Friedman, S; Glassman, A; Kollman, C; Lazarus, H; Strauber, S | 1 |
| Ferreri, G; Meduri, A; Meduri, RA; Morara, M; Reggiani, LB; Scalinci, SZ; Scorolli, L | 1 |
| Gómez-Ulla, F; López Gálvez, MI | 1 |
| Dowler, JG; Hykin, PG; Kok, HS; Lightman, S; Menezo, V; Morris, A; Okhravi, N | 1 |
| Ahmadieh, H; Anisian, A; Dehghan, MH; Entezari, M; Ramezani, A | 1 |
| Ahmadieh, H; Ramezani, A; Tabatabaie, H | 1 |
| Hirano, Y; Ogura, Y; Sakurai, E; Yoshida, M | 1 |
| Gillies, MC; Larsson, J | 1 |
| Bhatnagar, P; Kaiser, PK; Margolis, R; Singh, RP | 1 |
| Arevalo, JF; Berrocal, MH; Garcia, RA; Garcia-Amaris, R; Novoa, LA; Rodríguez, A; Rodriguez, FJ; Sanchez, JG; Wu, L | 1 |
| Bardak, H; Bardak, Y; Cekiç, O; Tiğ, US; Yildizoğlu, U | 1 |
| Amselem, L; Cervera, E; Díaz-Llopis, M; García-Delpech, S; Montero, J; Torralba, C | 1 |
| Bauer, D; Hilgers, RD; Joussen, AM; Weiss, C | 1 |
| Kumar, BV; Prasad, S; Salvi, SM | 1 |
| Stefánsson, E | 1 |
| Chang, YC; Wu, WC | 1 |
| Demirci, G; Gulkilik, G; Muftuoglu, GI; Ozdamar, AM | 1 |
| Kociecki, J; Lubczyńska, A | 2 |
| Kolluru, C; Krishnadas, R; Mahalakshmi, R; Prasad, NM; Shukla, D; Vidhya, N | 1 |
| Krishnan, R; Kumar, N; Wishart, PK | 1 |
| Brasil, OM; Galor, A; Kaiser, PK; Lowder, CY; Margolis, R; Perez, VL; Sears, JE; Smith, SD | 1 |
| Ahmadieh, H; Azarmina, M; Bijanzadeh, B; Keshavarzi, G; Mohebbi, MR; Ramezani, A; Shoeibi, N; Soheilian, M; Tabatabaei, A | 1 |
| Cho, HY; Kang, JH; Kang, SW; Park, SC | 1 |
| Al-Dhibi, H; Al-Saati, A; Chaudhry, IA; Shamsi, FA | 1 |
| Fukushima, M; Inatani, M; Inomata, Y; Iwao, K; Kawaji, T; Sagara, N; Takano, A; Tanihara, H | 1 |
| Barbosa, JC; Costa, RA; Folgosa, MS; Jorge, R; Paccola, L; Scott, IU | 1 |
| Choudhry, S; Ghosh, S | 1 |
| Asano, S; Miyake, K; Miyake, S; Ota, I | 1 |
| Akmese, E; Batioglu, F; Ozmert, E | 1 |
| Deren, YT; Gurelik, G; Hasanreisoglu, B; Ozdek, S | 1 |
| Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F | 1 |
| Faro, S; Longo, A; Motta, L; Reibaldi, M | 1 |
| Belfínová, S; Fidranská, H; Frdlíková, D; Kozlerová, S; Rusnák, S | 1 |
| Andrews, R; Chang, JH; Comer, RM; Grigg, JR; Lightman, S; McCluskey, PJ; Sallam, A | 1 |
| Contreras, I; Figueroa, MS; Noval, S | 1 |
| Acar, N; Altan, T; Bayraktar, S; Bayraktar, Z; Cakir, M; Dogan, M; Kapran, Z; Yilmaz, OF | 1 |
| Iida, T; Nakazawa, T; Nishida, K; Sakamoto, T; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Allingham, RR; Fekrat, S; Im, L; Singh, I; Stinnett, S | 1 |
| Campos, EC; Cellini, M; Leonetti, P; Pazzaglia, A; Zamparini, E | 1 |
| Fraser-Bell, S; Hykin, PG; Kaines, A | 1 |
| Bunce, C; Falk, S; Gregor, Z; Hykin, P; Ockrim, ZK; Roghani, S; Sivaprasad, S | 1 |
| Collin, JR; Meligonis, G; Morley, AM; Tumuluri, K | 1 |
| Chung, EJ; Koh, HJ; Lee, H | 1 |
| Matsubara, A; Mizuno, D; Ogura, Y | 1 |
| Chibani, A; Feldman-Billard, S; Héron, E | 1 |
| Kim, JE; Miller, DG; Mittra, RA; Pollack, JS; Spaide, RF | 1 |
| Kim, SY; Lee, YC; Park, YH; Yang, J | 1 |
| Erie, JC; Kalina, PH; Rosenbaum, L | 1 |
| Dugel, PU; Flindall, RJ; Sipperley, JO; Sneed, SR; Thach, AB | 1 |
| Shorstein, NH | 1 |
| Rho, D | 1 |
| Greenwald, MA; Vick, VL; Walton, RC | 1 |
| Dodds, EM; Lowder, CY; Meisler, DM | 1 |
| Antcliff, RJ; ffytche, TJ; Graham, EM; Marshall, J; Spalton, DJ; Stanford, MR | 1 |
| Gendron, EK; Maguire, AM; Prenner, JL; Tolentino, MJ | 1 |
| Jonas, JB; Söfker, A | 1 |
| Duker, JS; Martidis, A; Puliafito, CA | 1 |
| Duker, JS; Greenberg, PB; Martidis, A; Reichel, E; Rogers, AH | 1 |
| Baumal, C; Duker, JS; Greenberg, PB; Martidis, A; Puliafito, CA; Reichel, E; Rogers, AH | 1 |
| Agarwal, S; Mohney, BG | 1 |
| George, RK; Rosenbaum, JT; Smith, JR | 1 |
| Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P | 1 |
60 review(s) available for triamcinolone acetonide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Efficacy and safety of triamcinolone acetonide injection combined with laser photocoagulation in the treatment of diabetic macular edema: a systematic review and meta-analysis.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Light Coagulation; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2021 |
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
Topics: Choroidal Effusions; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Multicenter Studies as Topic; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2022 |
Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.
Topics: Cataract; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Macular Edema; Phacoemulsification; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
Noninfectious endophthalmitis following intravitreal triamcinolone acetonide: clinical case and literature review.
Topics: Aged, 80 and over; Endophthalmitis; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2020 |
Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression.
Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide | 2021 |
Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.
Topics: Animals; Blood Flow Velocity; Blood-Retinal Barrier; Capillary Permeability; Cytokines; Diabetes Complications; Diabetic Retinopathy; Humans; Hypoxia; Inflammation; Intravitreal Injections; Macular Edema; Receptors, Vascular Endothelial Growth Factor; Retina; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2021 |
Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Eye Infections, Fungal; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Mycoses; Postoperative Complications; Scedosporium; Scleritis; Tenon Capsule; Triamcinolone Acetonide; Voriconazole | 2018 |
Comparison of intravitreal triamcinolone acetonide with intravitreal bevacizumab for treatment of diabetic macular edema: a meta-analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Humans; Immunosuppressive Agents; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide | 2013 |
[Randomized clinical trials in diabetic macular edema].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Biomarkers; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetic Retinopathy; Double-Blind Method; Humans; Laser Coagulation; Macular Edema; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Ranibizumab; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
[From scientific evidence to clinical practice: treatment protocols for diabetic macular edema].
Topics: Algorithms; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Clinical Protocols; Diabetic Retinopathy; Drug Approval; European Union; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Microscopy, Acoustic; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Translational Research, Biomedical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2012 |
[BRAVO and CRUISE: ranibizumab for the treatment of macular edema secondary to retinal vein occlusion].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Biomarkers; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Implants; Follow-Up Studies; Humans; Intravitreal Injections; Laser Coagulation; Macula Lutea; Macular Edema; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
Topics: Animals; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide | 2014 |
Update of intravitreal steroids for the treatment of diabetic macular edema.
Topics: Diabetic Retinopathy; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide | 2014 |
Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2014 |
Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Injections; Macular Edema; Randomized Controlled Trials as Topic; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
Intravitreal triamcinolone acetonide in the treatment of ophthalmic inflammatory diseases with macular edema: a meta-analysis study.
Topics: Aged; Eye Diseases; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.
Topics: Cataract; Dexamethasone; Diabetic Retinopathy; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2015 |
RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT.
Topics: Angiogenesis Inhibitors; Bevacizumab; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2016 |
On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.
Topics: Bevacizumab; Diabetic Retinopathy; Humans; Linear Models; Macula Lutea; Macular Edema; Ranibizumab; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Intravitreal triamcinolone in diabetic retinopathy.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Fovea Centralis; Humans; Macular Edema; Models, Molecular; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
Topics: Aged; Databases, Factual; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Dyes in ocular surgery: principles for use in chromovitrectomy.
Topics: Benzenesulfonates; Coloring Agents; Epiretinal Membrane; Humans; Indocyanine Green; Macular Edema; Retinal Perforations; Rosaniline Dyes; Staining and Labeling; Triamcinolone Acetonide; Trypan Blue; Vitrectomy; Vitreoretinopathy, Proliferative | 2009 |
[Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Microinjections; Treatment Outcome; Triamcinolone Acetonide | 2009 |
Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment: a meta-analysis.
Topics: Databases, Factual; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
[Retinal vein occlusion: anti-VEGF treatments].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood-Retinal Barrier; Clinical Trials as Topic; Humans; Macular Edema; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2009 |
Cataract surgery and diabetes.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Disease Progression; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Phacoemulsification; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Update on treatments of diabetic macular edema.
Topics: Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Protein Kinase C; Protein Kinase C beta; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy | 2009 |
Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2012 |
Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
On the retinal toxicity of intraocular glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Cell Death; Choroidal Neovascularization; Endothelium, Vascular; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retina; Retinal Diseases; Retinal Neovascularization; Triamcinolone Acetonide | 2010 |
[Diabetic maculopathy. Diagnosis and treatment].
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glycated Hemoglobin; Humans; Intravitreal Injections; Ischemia; Laser Coagulation; Macular Edema; Ophthalmoscopy; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macula Lutea; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Diabetic macular edema.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetic Retinopathy; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2010 |
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.
Topics: Anti-Inflammatory Agents; Blood-Retinal Barrier; Delayed-Action Preparations; Diabetic Retinopathy; Drug Delivery Systems; Eye; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dexamethasone; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prostheses and Implants; Ranibizumab; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2011 |
Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dexamethasone; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prostheses and Implants; Ranibizumab; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2011 |
[Drug therapy for diabetic macular edema].
Topics: Antibodies; Diabetic Retinopathy; Humans; Macular Edema; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema.
Topics: Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide | 2011 |
Clinical development of new treatments for diabetic macular oedema.
Topics: Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cataract Extraction; Dexamethasone; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Pregnadienetriols; Tomography, Optical Coherence; Triamcinolone Acetonide | 2012 |
Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
Topics: Clinical Trials as Topic; Diabetic Retinopathy; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Tenon Capsule; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2012 |
IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Humans; Intravitreal Injections; Light Coagulation; Macular Edema; Triamcinolone Acetonide | 2012 |
Acute idiopathic frosted branch angiitis in an 11-month-old infant treated with intravitreal triamcinolone acetonide.
Topics: Anti-Inflammatory Agents; Humans; Infant; Intravitreal Injections; Macular Edema; Male; Retinal Vasculitis; Triamcinolone Acetonide; Vision Disorders | 2012 |
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Topics: Adrenal Cortex Hormones; Biological Availability; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Posterior Eye Segment; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis, Posterior | 2012 |
[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Retinal Neovascularization; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
[Diabetic maculopathy - classification and therapy].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Injections; Laser Coagulation; Macular Edema; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2004 |
[The management for macular edema].
Topics: Adrenal Cortex Hormones; Capillary Permeability; Cytokines; Decompression, Surgical; Drug Design; Humans; Macular Edema; Ophthalmologic Surgical Procedures; Prostaglandins; Retinal Artery; Retinal Vein; Retinal Vein Occlusion; Tissue Plasminogen Activator; Triamcinolone Acetonide; Vitrectomy | 2004 |
[Pharmacological treatment of diabetic retinopathy].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Injections; Macular Edema; Multicenter Studies as Topic; Octreotide; Prospective Studies; Protein Kinase C; Somatostatin; Triamcinolone Acetonide; Vitreous Body | 2004 |
[Strategies for treatment of diabetic retinopathy].
Topics: Cataract; Diabetic Retinopathy; Humans; Injections, Intralesional; Laser Coagulation; Macular Edema; Triamcinolone Acetonide; Vitrectomy | 2005 |
[Medications for diabetic macular edema].
Topics: Acetazolamide; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Humans; Indoles; Injections, Intralesional; Macular Edema; Maleimides; Prognosis; Protein Kinase C; Protein Kinase C beta; Pyrroles; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2005 |
[Surgical management of macular edema].
Topics: Capillary Permeability; Combined Modality Therapy; Diabetic Retinopathy; Humans; Interleukin-6; Macular Edema; Oxygen; Partial Pressure; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vitrectomy | 2005 |
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Topics: Choroidal Neovascularization; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body | 2005 |
The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
Topics: Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
Infectious crystalline keratopathy associated with intravitreal and posterior sub-Tenon triamcinolone acetonide injections.
Topics: Aged; Cornea; Crystallization; Glucocorticoids; Humans; Injections; Keratitis; Macular Edema; Male; Triamcinolone Acetonide | 2006 |
Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal steroids in the management of macular oedema.
Topics: Dexamethasone; Fluocinolone Acetonide; Glucocorticoids; Humans; Inflammation; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Müller cells as players in retinal degeneration and edema.
Topics: Animals; Biological Transport; Body Fluids; Capillary Permeability; Glucocorticoids; Humans; Macular Edema; Neuroglia; Retina; Retinal Degeneration; Triamcinolone Acetonide | 2007 |
Update on treatments for diabetic macular edema.
Topics: Diabetes Complications; Enzyme Inhibitors; Fluocinolone Acetonide; Glucocorticoids; Humans; Indoles; Injections; Laser Coagulation; Macular Edema; Maleimides; Protein Kinase C; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2008 |
164 trial(s) available for triamcinolone acetonide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE.
Topics: Glucocorticoids; Humans; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2022 |
Combined phacoemulsification surgery and intravitreal triamcinolone injection versus stand-alone surgery in patients with type 2 diabetes: a prospective randomized trial.
Topics: Cataract; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2022 |
Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial.
Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Iran; Macular Edema; Pilot Projects; Treatment Outcome; Triamcinolone Acetonide | 2023 |
Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Field Tests; Visual Fields | 2020 |
Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Implants; Equivalence Trials as Topic; Female; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
Topics: Choroid; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2020 |
Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Diabetic Retinopathy; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2021 |
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).
Topics: Glucocorticoids; Humans; Macular Edema; Magnolia; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2022 |
COMBINED TREATMENT WITH BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE FOR MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Glucocorticoids; Humans; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Economic evaluation of prevention of cystoid macular edema after cataract surgery in diabetic patients: ESCRS PREMED study report 6.
Topics: Bevacizumab; Cataract; Cost-Benefit Analysis; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2022 |
Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity | 2018 |
Multicenter, Randomized Clinical Trial to Assess the Effectiveness of Intravitreal Injections of Bevacizumab, Triamcinolone, or Their Combination in the Treatment of Diabetic Macular Edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Visual Acuity | 2017 |
Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Aqueous Humor; Bevacizumab; Cytokines; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
Topics: Aged; Angiogenesis Inhibitors; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Nerve Fibers; Organ Size; Prospective Studies; Ranibizumab; Retinal Ganglion Cells; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Topics: Adult; Aged; Aged, 80 and over; Choroid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema.
Topics: Angiogenesis Inhibitors; Case-Control Studies; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Ranibizumab; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2019 |
Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bevacizumab; Bromobenzenes; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intraocular; Intravitreal Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).
Topics: Adult; Aged; Aged, 80 and over; Choroid; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Young Adult | 2019 |
Phase II/III Clinical Trial of Sub-Tenon Injection of Triamcinolone Acetonide (WP-0508ST) for Diabetic Macular Edema.
Topics: Adult; Aged; Diabetic Retinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tenon Capsule; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2019 |
Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema.
Topics: Aged; Choroid; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Flare levels after intravitreal injection of ranibizumab, aflibercept, or triamcinolone acetonide for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration Routes; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Young Adult | 2019 |
Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Biometry; Cataract Extraction; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2019 |
The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Topics: Administration, Ophthalmic; Adult; Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide | 2020 |
Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery.
Topics: Aged; Conjunctiva; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Phacoemulsification; Postoperative Care; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2014 |
A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Young Adult | 2013 |
Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Drug Combinations; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2013 |
Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Cytokines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
[Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Middle Aged; Ocular Hypertension; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2013 |
Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Refractive changes after pharmacologic resolution of diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Refraction, Ocular; Refractive Errors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Therapy; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Case-Control Studies; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2014 |
Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2014 |
Intravitreal bevacizumab versus posterior subtenon triamcinolone in diffuse diabetic macular edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Bevacizumab; Chemotherapy, Adjuvant; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Laser Therapy; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Visual Acuity | 2015 |
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Topics: Aged; Dexamethasone; Diabetes Complications; Drug Implants; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macular Edema; Male; Pseudophakia; Treatment Outcome; Triamcinolone Acetonide | 2014 |
Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Topics: Adrenocorticotropic Hormone; Aged; Blood Glucose; Diabetes Complications; Female; Glucocorticoids; Humans; Hydrocortisone; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide | 2014 |
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.
Topics: Aged; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Visual Acuity | 2014 |
OCT parameters in patients with diabetic maculopathy.
Topics: Angiogenesis Inhibitors; Bevacizumab; Case-Control Studies; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide | 2014 |
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Risk Factors; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2015 |
Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Topics: Administration, Topical; Aged; Dexamethasone; Diabetic Retinopathy; Female; gamma-Cyclodextrins; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Nanoparticles; Ophthalmic Solutions; Prospective Studies; Retina; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2015 |
Intravitreal Triamcinolone Injection for Uveitic Macular Edema: A Randomized Clinical Study.
Topics: Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2015 |
The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2016 |
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
Topics: Aged; Angiogenesis Inhibitors; Dexamethasone; Diabetic Retinopathy; Drug Implants; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.
Topics: Aged; Angiogenesis Inhibitors; Combined Modality Therapy; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Single-Blind Method; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Phenylacetates; Prospective Studies; Pseudophakia; Retina; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2017 |
Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
Topics: Aged; Aged, 80 and over; Dexamethasone; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Postoperative Complications; Prospective Studies; Retina; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2017 |
Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
Topics: Aged; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2008 |
Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vessels; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Cataract surgery in uveitis.
Topics: Administration, Oral; Anterior Chamber; Cataract; Combined Modality Therapy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Intraoperative Care; Lens Implantation, Intraocular; Macular Edema; Phacoemulsification; Prednisolone; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2008 |
[Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.
Topics: Aged; Diabetic Retinopathy; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Tissue Distribution; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
Topics: Anti-Inflammatory Agents; Chronic Disease; Drug Administration Routes; Female; Humans; Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Orbit; Phacoemulsification; Postoperative Care; Prospective Studies; Pseudophakia; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Diabetic Retinopathy; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Young Adult | 2009 |
Intravitreal triamcinolone.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Double-Blind Method; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.
Topics: Aged; Cataract; Cataract Extraction; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
Topics: Brachytherapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Iodine Radioisotopes; Macular Edema; Male; Melanoma; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveal Neoplasms; Visual Acuity | 2009 |
Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
SCORE Study report 3: study design and baseline characteristics.
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Research Design; Retina; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
Topics: Blindness; Equipment Design; Eye Foreign Bodies; Glucocorticoids; Humans; Incidence; Injections; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Silicone Oils; Syringes; Triamcinolone Acetonide; Vitreous Body | 2009 |
Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone.
Topics: Aged; Diabetic Retinopathy; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prognosis; Proportional Hazards Models; Recurrence; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Observation; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlu
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body; Young Adult | 2009 |
Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Middle Aged; Postoperative Period; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Topics: Diabetic Retinopathy; Double-Blind Method; Glucocorticoids; Humans; Injections; Macular Edema; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.
Topics: Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Quality Control; Reproducibility of Results; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2009 |
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.
Topics: Diabetic Retinopathy; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Probability; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Topics: Chemotherapy, Adjuvant; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema.
Topics: Diabetic Retinopathy; Female; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.
Topics: Aged; Anti-Inflammatory Agents; Cataract Extraction; Diabetic Retinopathy; Drug Administration Routes; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intraocular Pressure; Macular Edema; Male; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2010 |
Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Bevacizumab vs. triamcinolone.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Pilot Projects; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Topics: Aged; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Intraocular Pressure; Lens Implantation, Intraocular; Macula Lutea; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial.
Topics: Aged; Cataract; Cataract Extraction; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Risk Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
[Prognostic factors for visual outcome after intravitreal drug therapy for chronic diabetic macular oedema].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chronic Disease; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intravitreal Injections; Macular Edema; Male; Prognosis; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2011 |
Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.
Topics: Aged; Aged, 80 and over; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Observer Variation; Photography; Quality Control; Reproducibility of Results; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2010 |
A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes.
Topics: Administration, Topical; Aged; Choroidal Neovascularization; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2010 |
A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Topics: Anthropometry; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prognosis; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2011 |
Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Topics: Aged; Cataract; Cataract Extraction; Combined Modality Therapy; Diabetic Retinopathy; Disease Progression; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Lens, Crystalline; Macular Edema; Middle Aged; Ocular Hypertension; Orbit; Risk Factors; Tenon Capsule; Triamcinolone Acetonide | 2011 |
Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2011 |
Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Humans; Immunosuppressive Agents; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide | 2011 |
Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Postoperative Care; Ranibizumab; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Sustained-release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2011 |
Initial macular thickness and response to treatment in diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Body Weights and Measures; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Laser Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Prospective Studies; Recurrence; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Young Adult | 2012 |
Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Antihypertensive Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Laser Therapy; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide | 2011 |
Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retreatment; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
Topics: Aged; Female; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2012 |
Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Immunotherapy; Macular Edema; Male; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Vision, Ocular; Young Adult | 2012 |
The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2013 |
Score Study Report 12: Development of venous collaterals in the Score Study.
Topics: Collateral Circulation; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Optic Disk; Retinal Vein; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2013 |
A three-year follow-up of intravitreal triamcinolone acetonide injection and macular laser photocoagulation for diffuse diabetic macular edema.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Intravitreal Injections; Macular Edema; Male; Middle Aged; Pituitary-Adrenal System; Prospective Studies; Triamcinolone Acetonide | 2013 |
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Safety; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Topics: Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
[Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Risk Assessment; Risk Factors; Treatment Outcome; Triamcinolone Acetonide | 2005 |
Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Failure; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone injection for macular edema secondary to increased retinal vascular permeability.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Topics: Aged; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Prospective Studies; Safety; Treatment Failure; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Pilot Projects; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Topics: Aged; Chronic Disease; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
Topics: Adult; Aged; Aged, 80 and over; Body Weights and Measures; Diabetic Retinopathy; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
Topics: Combined Modality Therapy; Connective Tissue; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Orbit; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Topics: Aged; Blood; Diabetic Retinopathy; Drug Evaluation; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ophthalmoscopy; Recurrence; Retinal Detachment; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Topics: Adult; Aged; Connective Tissue; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Safety; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone for diffuse diabetic macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
Topics: Connective Tissue; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Parenteral; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
[Intravitreal triamcinolone acetonide for diffuse diabetic macular edema--one year follow-up].
Topics: Anti-Inflammatory Agents; Follow-Up Studies; Humans; Injections; Macular Edema; Retina; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial.
Topics: Administration, Topical; Aged; Anterior Chamber; Betamethasone; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Lens Implantation, Intraocular; Macular Edema; Male; Perioperative Care; Phacoemulsification; Postoperative Complications; Prospective Studies; Triamcinolone Acetonide; Visual Acuity | 2006 |
Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.
Topics: Adult; Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study.
Topics: Aged; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Topics: Aged; Diabetic Retinopathy; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Middle Aged; Prospective Studies; Recurrence; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Diabetic Retinopathy; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests | 2007 |
[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].
Topics: Adult; Aged; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cataract; Diabetic Retinopathy; Disease Progression; Endophthalmitis; Female; Glaucoma; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
Topics: Aged; Cataract; Diabetic Retinopathy; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
Topics: Drug Administration Schedule; Female; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Orbit; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone.
Topics: Adult; Cornea; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Retinitis Pigmentosa; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Intraoperative Care; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2007 |
A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.
Topics: Adult; Aged; Body Weights and Measures; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Prognosis; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Diabetic macular edema before and after intravitreal triamcinolone injection.
Topics: Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): design issues and implications.
Topics: Diabetic Retinopathy; Endpoint Determination; Glucocorticoids; Humans; Injections; Macular Edema; Ophthalmologic Surgical Procedures; Prospective Studies; Research Design; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Relationship between blood-aqueous barrier disruption and ischemic macular edema in patients with branch or central retinal vein occlusion: effects of sub-tenon triamcinolone acetonide injection.
Topics: Aged; Aged, 80 and over; Blood-Aqueous Barrier; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Detachment; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Topics: Aged; Basement Membrane; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Connective Tissue; Decompression, Surgical; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone for refractory diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Drug Evaluation; Glucocorticoids; Humans; Injections; Interferometry; Laser Coagulation; Light; Macular Edema; Middle Aged; Prospective Studies; Tomography; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Prospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 1992 |
533 other study(ies) available for triamcinolone acetonide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report.
Topics: Adolescent; Female; Glucocorticoids; Humans; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2021 |
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?
Topics: Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide; Uveitis | 2022 |
Suprachoroidal injection of triamcinolone acetonide using a custom-made needle to treat diabetic macular edema post pars plana vitrectomy: a case series.
Topics: Cataract; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2022 |
First case of endophthalmitis by Corynespora cassiicola.
Topics: Ascomycota; Endophthalmitis; Humans; Macular Edema; Middle Aged; Triamcinolone Acetonide | 2022 |
IRVAN syndrome: A retrospective review of 9 cases from Tunisia.
Topics: Aneurysm; Bevacizumab; Fundus Oculi; Humans; Indocyanine Green; Macular Edema; Retinal Vasculitis; Retinitis; Retrospective Studies; Triamcinolone Acetonide; Tunisia | 2022 |
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.
Topics: Aged; Cost-Benefit Analysis; Glucocorticoids; Humans; Macular Edema; Medicare; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; United States; Uveitis; Visual Acuity | 2022 |
Acute macular neuroretinopathy in a patient with birdshot chorioretinopathy after intravitreal triamcinolone suspension injection.
Topics: Birdshot Chorioretinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body; White Dot Syndromes | 2023 |
Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.
Topics: Cataract; Dexamethasone; Glucocorticoids; Humans; Inflammation; Macular Edema; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2022 |
Effect of triamcinolone acetonide on retinal inflammation and angiogenesis induced by pericyte depletion in mouse.
Topics: Animals; Cytokines; Diabetic Retinopathy; Endothelial Cells; Inflammation; Macular Edema; Mice; Pericytes; Retina; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2023 |
Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema.
Topics: Cataract; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2022 |
Posterior sub-Tenon triamcinolone injection in the treatment of postoperative cystoid macular edema secondary to pars plana vitrectomy.
Topics: Glucocorticoids; Humans; Macular Edema; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2023 |
Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study.
Topics: Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Pilot Projects; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2023 |
Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety.
Topics: Choroid; Glucocorticoids; Humans; Macular Edema; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular oedema.
Topics: Adult; Diabetes Mellitus; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide | 2023 |
Pseudo endophthalmitis following intravitreal triamcinolone acetonide for cystoid macular edema in a post-vitrectomised eye.
Topics: Aged; Endophthalmitis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Photochemotherapy; Photosensitizing Agents; Triamcinolone Acetonide; Vitreous Body | 2023 |
Comment on: Posterior sub-Tenon triamcinolone injection in the treatment of postoperative cystoid macular edema secondary to pars plana vitrectomy.
Topics: Glucocorticoids; Humans; Macular Edema; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2023 |
Response to comment on: Posterior sub-Tenon triamcinolone injection in the treatment of postoperative cystoid macular edema secondary to pars plana vitrectomy.
Topics: Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide; Vitrectomy | 2023 |
Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Macular Edema; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2023 |
Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Topics: Dexamethasone; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide | 2023 |
Refractory post-surgical cystoid macular edema managed following suprachoroidal microcatheterization and delivery of triamcinolone.
Topics: Choroid; Humans; Intraocular Pressure; Macular Edema; Triamcinolone Acetonide | 2023 |
IS A DECREASED NITRIC OXIDE CONCENTRATION AFTER TRIAMCINOLONE ACETONIDE INTRAVITREAL INJECTION ONE OF THE REASONS FOR INTRAOCULAR PRESSURE RISE?
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Nitric Oxide; Triamcinolone Acetonide; Vitreous Body | 2022 |
Inner Nuclear Layer Cystic Changes in Phakic Fellow Eyes of Patients With Acute Pseudophakic Cystoid Macular Edema.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Female; Humans; Macular Edema; Male; Middle Aged; Pseudophakia; Treatment Outcome; Triamcinolone Acetonide | 2019 |
Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
Topics: Adolescent; Adult; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinitis Pigmentosa; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Young Adult | 2020 |
The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2021 |
Predictive factors of outcome of selective retina therapy for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Diabetic Retinopathy; Disease Management; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections, Intraocular; Laser Coagulation; Macular Edema; Male; Middle Aged; Prognosis; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2020 |
Rebound Phenomenon after Intravitreal Injection of Triamcinolone Acetonide for Macular Edema.
Topics: Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Evaluating the effect of intravitreal triamcinolone-moxifloxacin during cataract surgery on central macular edema in patients with preexisting diabetic retinopathy.
Topics: Cataract; Diabetes Mellitus; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Moxifloxacin; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Central serous chorioretinopathy secondary to subtenon triamcinolone injection: A new hypothesis for the mechanism.
Topics: Central Serous Chorioretinopathy; Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide | 2020 |
Case Report: Suprachoroidal Hemorrhage after Chiropractic Manipulation of the Neck.
Topics: Adult; Choroid Hemorrhage; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Manipulation, Chiropractic; Neck Pain; Retinal Detachment; Slit Lamp Microscopy; Triamcinolone Acetonide; Ultrasonography | 2020 |
Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option.
Topics: Aged; Cornea; Female; Glucocorticoids; Humans; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Orbital abscess caused by Exophiala dermatitidis following posterior subtenon injection of triamcinolone acetonide: a case report and a review of literature related to Exophiala eye infections.
Topics: Abscess; Aged; Anti-Inflammatory Agents; Antifungal Agents; Dermatitis; Exophiala; Eye Infections; Female; Humans; Macular Edema; Triamcinolone Acetonide; Voriconazole | 2020 |
Surgical outcomes of vitrectomy for intractable diabetic macular edema.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Humans; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2021 |
Management of Cystoid Macular Edema After Vitrectomy for Proliferative Vitreoretinopathy.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Disease Management; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2020 |
One-year results of anti-vascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.
Topics: Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2020 |
Incidence and Outcomes of Cystoid Macular Edema after Descemet Membrane Endothelial Keratoplasty (DMEK) and DMEK Combined with Cataract Surgery.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract; Cataract Extraction; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Female; Humans; Incidence; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Prednisolone; Retrospective Studies; Risk Factors; Slit Lamp Microscopy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2021 |
Periocular steroids for macular edema associated with retinal arteriovenous malformation: A case report.
Topics: Adult; Angiogenesis Inhibitors; Arteriovenous Malformations; Bevacizumab; Glucocorticoids; Hemangioma; Humans; Macular Edema; Male; Neoplasm Recurrence, Local; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2020 |
Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Tenon Capsule; Tonometry, Ocular; Triamcinolone Acetonide | 2021 |
Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion.
Topics: Aged; Cytokines; Diabetic Retinopathy; Eye; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Management of a case of bilateral dengue maculopathy with intravitreal steroid therapy.
Topics: Dengue; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Triamcinolone Acetonide | 2021 |
Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pseudophakia; Retreatment; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2021 |
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).
Topics: Eye Infections, Bacterial; Glucocorticoids; Humans; Macular Edema; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2022 |
Modified inexpensive needle for suprachoroidal triamcinolone acetonide injections in pseudophakic cystoid macular edema.
Topics: Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2021 |
Effect of Periocular Triamcinolone Acetonide on Prevention of Postsurgical Intraretinal Cystoid Changes after Vitrectomy with Membrane Peeling.
Topics: Edema; Epiretinal Membrane; Glucocorticoids; Humans; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2022 |
Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retina; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2018 |
[Treatment of macular edema: Comparison of efficacy and tolerability of subconjunctival triamcinolone injections, sub-tenon's triamcinolone injections and intravitreal dexamethasone implant].
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Drug Implants; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide | 2017 |
Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Tenon Capsule; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Intermediate; Visual Acuity; Young Adult | 2017 |
Vessel diameter study: intravitreal vs posterior subtenon triamcinolone acetonide injection for diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Artery; Retinal Vein; Tenon Capsule; Triamcinolone Acetonide; Vasodilation | 2017 |
Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2017 |
Orbital abscess following posterior subtenon injection of triamcinolone acetonide.
Topics: Abscess; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Floxacillin; Glucocorticoids; Humans; Infusions, Intravenous; Injections, Intraocular; Macular Edema; Magnetic Resonance Imaging; Male; Metronidazole; Middle Aged; Orbital Cellulitis; Tenon Capsule; Triamcinolone Acetonide | 2017 |
Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series.
Topics: Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2017 |
Cystoid macular oedema associated with Rosai-Dorfman disease: a case report.
Topics: Anti-Inflammatory Agents; Histiocytosis, Sinus; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide | 2017 |
High-Dose Decanted Triamcinolone for Treatment-Resistant Persistent Macular Edema.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2017 |
Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Diabetic Retinopathy; Drug Implants; Exudates and Transudates; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2017 |
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Ocular Features of Cerebro-Costo-Mandibular Syndrome.
Topics: Atropine; Chronic Disease; Consanguinity; Female; Glaucoma, Angle-Closure; Glucocorticoids; Gonioscopy; Humans; Intellectual Disability; Intraocular Pressure; Iris; Laser Coagulation; Lens, Crystalline; Macular Edema; Micrognathism; Mydriatics; Ribs; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Young Adult | 2018 |
Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2019 |
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Crystallization; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Microscopy, Electron, Transmission; Middle Aged; Retina; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2019 |
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retina; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2018 |
Choroidal Changes After Suprachoroidal Injection of Triamcinolone in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Topics: Choroid; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2018 |
Reply.
Topics: Choroid; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2018 |
Vitreous opacities after intravitreal triamcinolone injection- a case report.
Topics: Adult; Aged; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2018 |
[Steroid implant in treatment of sympathetic ophthalmia : Intravitreal implant of dexamethasone in cystoid macular edema in the context of sympathetic ophthalmia].
Topics: Adult; Dexamethasone; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Ophthalmia, Sympathetic; Triamcinolone Acetonide | 2019 |
Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
Topics: Aged; Cataract; Cataract Extraction; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraoperative Period; Intravitreal Injections; Macular Edema; Male; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2019 |
Combined Intravitreal Triamcenolone Acetonide and Bevacizumab for Refractory Diabetic Macular Edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Treatment Outcome; Triamcinolone Acetonide | 2018 |
Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Cattle; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Glucocorticoids; Macular Edema; Retinal Vessels; Tight Junctions; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2019 |
OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Uveitis, Posterior | 2020 |
Rare Complication of Sclerochoroidal Calcifications.
Topics: Aged; Angiogenesis Inhibitors; Calcinosis; Calcium; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Epiretinal Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Macular Edema; Parathyroid Hormone; Retinal Drusen; Scleral Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Vision Disorders; Visual Fields; Vitamin D | 2019 |
Assessing patient acceptance of laser pretreatment to reduce injection burden in diabetic macular edema: a large scale postal survey.
Topics: Aged; Attitude to Health; Diabetic Retinopathy; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Needs Assessment; Surveys and Questionnaires; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Wales | 2018 |
Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
Topics: Aged; Anti-Inflammatory Agents; Cataract Extraction; Drug Compounding; Drug Tolerance; Female; Humans; Intravitreal Injections; Liposomes; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Triamcinolone Acetonide | 2019 |
[Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2012 |
Acute glaucoma in a patient with an Artisan® due to trabecular blockage after combined intravitreal treatment for macular oedema.
Topics: Acute Disease; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Lenses, Intraocular; Macular Edema; Male; Triamcinolone Acetonide | 2013 |
Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
The duration of effect of centrifuge concentrated intravitreal triamcinolone acetonide.
Topics: Biological Availability; Centrifugation; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vasculitis; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2013 |
Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Reading; Recovery of Function; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema.
Topics: Disease Progression; Epiretinal Membrane; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Detachment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Anterior; Visual Acuity | 2013 |
Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient.
Topics: Diabetic Retinopathy; Fluorescein Angiography; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Laser Coagulation; Lasers, Solid-State; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Trabeculectomy; Triamcinolone Acetonide; Visual Acuity | 2014 |
An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
Topics: Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ascomycota; Bevacizumab; Combined Modality Therapy; Disease Outbreaks; Drug Compounding; Drug Contamination; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Mycoses; New York; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2013 |
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Drug Costs; Financing, Personal; Glucocorticoids; Health Care Costs; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Ranibizumab; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2013 |
[Viral retinitis following intravitreal triamcinolone injection].
Topics: Aged; Cytomegalovirus Retinitis; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Male; Triamcinolone Acetonide | 2013 |
Retinal vasculitis, aneurysms, and neovascularization in Blau syndrome.
Topics: Aneurysm; Arthritis; Child; Combined Modality Therapy; Cranial Nerve Diseases; DNA Mutational Analysis; Fluorescein Angiography; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Nod2 Signaling Adaptor Protein; Peptidyl-Dipeptidase A; Retinal Artery; Retinal Neovascularization; Retinal Vasculitis; Retinitis; Sarcoidosis; Synovitis; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Humans; Immunosuppressive Agents; Intravitreal Injections; Light Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2013 |
Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Topics: Fovea Centralis; Glucocorticoids; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Retinoschisis; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2013 |
Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Female; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Turkey; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2013 |
Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arteriovenous Fistula; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Ketorolac Tromethamine; Macular Edema; Magnetic Resonance Imaging; Male; Neurocutaneous Syndromes; Prednisolone; Retinal Detachment; Subretinal Fluid; Sulfonamides; Thiophenes; Tomography, Optical Coherence; Triamcinolone Acetonide | 2015 |
The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Combinations; Eye Neoplasms; Glucocorticoids; Humans; Intravitreal Injections; Iodine Radioisotopes; Macular Edema; Radiation Injuries; Radiotherapy; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
[Comparison of visual acuity and central macular thickness after vitrectomy for diffuse diabetic macular edema with or without preoperative treatments].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Complications; Female; Humans; Injections, Intraocular; Intravitreal Injections; Lasers, Semiconductor; Light Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Preoperative Care; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2013 |
Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting.
Topics: Ambulatory Surgical Procedures; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Endophthalmitis; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Edema; Operating Rooms; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Wet Macular Degeneration | 2014 |
Analyses of Sequence Variants in the MYOC Gene and of Single Nucleotide Polymorphisms in the NR3C1 and FKBP5 Genes in Corticosteroid-Induced Ocular Hypertension.
Topics: Case-Control Studies; Cytoskeletal Proteins; Eye Proteins; Gene Frequency; Genetic Variation; Genotyping Techniques; Glucocorticoids; Glycoproteins; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Open Reading Frames; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Receptors, Glucocorticoid; Retrospective Studies; Tacrolimus Binding Proteins; Triamcinolone Acetonide | 2015 |
Improved visual outcome with early treatment in macular edema secondary to retinal vein occlusions: 6-month results of a Korean RVO study.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Secondary Prevention; Time Factors; Triamcinolone Acetonide; Visual Acuity | 2014 |
Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Ascomycota; Disease Outbreaks; Drug Compounding; Drug Contamination; Endophthalmitis; Eye Infections, Fungal; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Mycoses; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2014 |
Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion.
Topics: Aged; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2014 |
Cystoid macular edema from cancer-associated retinopathy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Lung Neoplasms; Macular Edema; Male; Paraneoplastic Syndromes, Ocular; Small Cell Lung Carcinoma; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2014 |
Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Cytokines; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Failure; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2014 |
Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Tenon Capsule; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Resistance; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
Optical coherence tomographic reflectivity of cystoid spaces is related to recurrent diabetic macular edema after triamcinolone.
Topics: Aged; Blood-Retinal Barrier; Capillary Permeability; Diabetic Retinopathy; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections, Intraocular; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Recurrence; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2015 |
Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Disease Progression; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2014 |
Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Nephelometry and Turbidimetry; Retina; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
[Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
Topics: Adult; Anti-Inflammatory Agents; Cataract; Conjunctiva; Drug Evaluation; Epiretinal Membrane; Female; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2014 |
Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
Topics: Adolescent; Adult; Aged; Australia; Child; Dexamethasone; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Methylprednisolone; Middle Aged; New Zealand; Ocular Hypertension; Product Surveillance, Postmarketing; Prospective Studies; Retinal Neovascularization; Risk Factors; Surveys and Questionnaires; Tonometry, Ocular; Trabeculectomy; Triamcinolone Acetonide | 2015 |
Bilateral exudative retinal detachment in a diabetic patient with severe peripheral retinal ischemia.
Topics: Aged; Angiogenesis Inhibitors; Diabetic Retinopathy; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Ischemia; Laser Coagulation; Macular Edema; Retinal Detachment; Retinal Vessels; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2015 |
Intravitreal triamcinolone acetonide treatment of tamoxifen maculopathy with associated cystoid macular edema.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Tamoxifen; Treatment Outcome; Triamcinolone Acetonide | 2015 |
[A cost-effectiveness study of dexamethasone implants in macular edema].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cataract; Cost-Benefit Analysis; Dexamethasone; Diabetic Retinopathy; Drug Implants; Female; Humans; Macular Edema; Male; Middle Aged; Off-Label Use; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitrectomy; Vitreous Body | 2015 |
EVOLUTION OF CONTROLLING DIABETIC RETINOPATHY: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Ophthalmology; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2015 |
Moment of cyst eruption captured by optical coherence tomography in diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Imaging, Three-Dimensional; Intravitreal Injections; Macular Edema; Middle Aged; Retinal Perforations; Subretinal Fluid; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2015 |
Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Topics: Adrenocorticotropic Hormone; Blood Glucose; Diabetes Complications; Female; Humans; Hydrocortisone; Macular Edema; Male; Triamcinolone Acetonide | 2015 |
Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Cross-Sectional Studies; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Photoreceptor Cells, Vertebrate; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Uveitic macular oedema after treatment with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Indoles; Macular Edema; Male; Melanoma; Middle Aged; Prednisone; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vemurafenib; Visual Acuity | 2015 |
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.
Topics: Adult; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Eye Diseases; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tissue Adhesions; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2015 |
THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Combinations; Drug Costs; Drug Implants; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling.
Topics: Choroiditis; Dexamethasone; Drug Implants; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Postoperative Complications; Retinal Detachment; Scleral Buckling; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2015 |
Visual acuity outcome in patients with diabetic maculopathy.
Topics: Bevacizumab; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2014 |
Sterile endophthalmitis following intravitreal triamcinolone acetonide in July 2010.
Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide | 2015 |
Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema.
Topics: Aged; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Linear Models; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
Vision loss and vascular compromise with facial and periocular injections.
Topics: Aged; Arterial Occlusive Diseases; Blindness; Cataract Extraction; Eye Pain; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Lacrimal Apparatus; Macular Edema; Magnetic Resonance Imaging; Oculomotor Muscles; Ophthalmic Artery; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide | 2015 |
Correspondence.
Topics: Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Female; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2015 |
Reply: To PMID 25748280.
Topics: Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Female; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2015 |
Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Flurbiprofen; Glucocorticoids; Humans; Injections, Intraocular; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prednisolone; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2015 |
Correspondence.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Female; Glucocorticoids; Humans; Macular Edema; Male; Triamcinolone Acetonide | 2015 |
Reply: To PMID 25105313.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Female; Glucocorticoids; Humans; Macular Edema; Male; Triamcinolone Acetonide | 2015 |
RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Sneddon's syndrome with optic disc macroaneurysm and macular edema successfully treated with subtenon steroid injection.
Topics: Aneurysm; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Optic Disk; Retinal Artery; Retinal Diseases; Sneddon Syndrome; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide | 2016 |
RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Chronic Disease; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Postoperative Complications; Recurrence; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2016 |
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Diabetic Retinopathy; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body | 2016 |
Intravitreal Triamcinolone Deposition Mimicking Frosted Branch Angiitis: Optical Coherence Tomography Findings.
Topics: Aged; Diabetic Retinopathy; Diagnosis, Differential; Eye Foreign Bodies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Vasculitis; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2016 |
[The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Topics: Anti-Inflammatory Agents; Conjunctiva; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Recurrence; Retreatment; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2015 |
Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Dexamethasone; Drug Implants; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2016 |
Combined occlusion of branch retinal artery and vein secondary to prepapillary arterial loops.
Topics: Combined Modality Therapy; Eye Abnormalities; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Optic Disk; Retinal Artery; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders | 2015 |
Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Failure; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion.
Topics: Demography; Dose-Response Relationship, Drug; Female; Humans; Intravitreal Injections; Light Coagulation; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2016 |
Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
Topics: Adult; Aged; Device Removal; Drug Implants; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Tenon Capsule; Tonometry, Ocular; Triamcinolone Acetonide | 2016 |
Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retrospective Studies; Tomography, Optical Coherence; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema.
Topics: Bevacizumab; Diabetic Retinopathy; Humans; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2016 |
Comments on 'Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants'.
Topics: Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2016 |
Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide.
Topics: Adult; Aged; Contrast Sensitivity; Electroretinography; Female; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2016 |
Bilateral Macular Edema: A New Ocular Feature of Dandy-Walker Syndrome.
Topics: Adolescent; Dandy-Walker Syndrome; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Magnetic Resonance Imaging; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2017 |
Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon's triamcinolone acetonide for uveitic cystoid macular oedema.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Humans; Inflammation; Injections, Intraocular; Longitudinal Studies; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2017 |
Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Female; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Melanoma; Middle Aged; Proton Therapy; Radiation Injuries; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Uveal Neoplasms; Visual Acuity | 2016 |
The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits.
Topics: Angiogenesis Inhibitors; Animals; Aqueous Humor; Bevacizumab; Biomarkers; Cytokines; Glucocorticoids; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Postoperative Period; Rabbits; Triamcinolone Acetonide; Vitreous Body | 2016 |
Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2016 |
Microaneurysms cause refractory macular edema in branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Combined Modality Therapy; Female; Humans; Intravitreal Injections; Light Coagulation; Macular Edema; Male; Microaneurysm; Ranibizumab; Regression Analysis; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2016 |
[Intravitreal Triamcinolone Acetonide for Persistent Diabetic Macular Edema after Vitrectomy].
Topics: Aged; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2016 |
Posterior subtenon injection of triamcinolone acetonide for pseudophakic cystoid macular oedema.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Pseudophakia; Triamcinolone Acetonide; Visual Acuity | 2018 |
Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Eye Proteins; Glucocorticoids; Humans; Macular Edema; Male; Membrane Proteins; Nerve Tissue Proteins; Point Mutation; Retinitis Pigmentosa; Tenon Capsule; Tomography, Optical Coherence; Treatment Failure; Triamcinolone Acetonide; Visual Acuity | 2016 |
Clinical Characteristics and Treatment Outcomes of Recurrent Central Retinal Vein Occlusions.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Receptors, Vascular Endothelial Growth Factor; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2018 |
Intraocular Pressure after Intravitreal Triesence Injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Triamcinolone Acetonide | 2018 |
Role of posterior sub-tenon triamcinolone acetonide in patients of refractory macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Pakistan; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2016 |
Primary iris claw IOL retrofixation with intravitreal triamcinolone acetonide in cases of inadequate capsular support.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Intravitreal Injections; Iris; Lens Implantation, Intraocular; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Young Adult | 2018 |
Bevacizumab and Panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Bevacizumab; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Light Coagulation; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2017 |
Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Topics: Adult; Aged; Drug Administration Schedule; Eyeglasses; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
Peribulbar fungal abscess and endophthalmitis following posterior subtenon injection of triamcinolone acetonide.
Topics: Abscess; Administration, Topical; Antifungal Agents; Connective Tissue; Diplopia; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Glucocorticoids; Humans; Infusions, Intravenous; Injections; Macular Edema; Magnetic Resonance Imaging; Male; Middle Aged; Mycetoma; Ophthalmologic Surgical Procedures; Orbital Diseases; Pain; Scedosporium; Triamcinolone Acetonide; Visual Acuity | 2009 |
Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Taiwan; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2009 |
[Central Retinal Vein Occlusion accompanied by positive testing of serum antineutrophil cytoplasmic antibodies (c-ANCA)].
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Aspirin; Combined Modality Therapy; Fluorescein Angiography; Granulomatosis with Polyangiitis; Hemodilution; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vasculitis; Vision Disorders; Vitreous Body | 2008 |
Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease.
Topics: Adolescent; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Neovascularization; Telangiectasis; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Cytomegalovirus retinitis after intravitreous triamcinolone injection in a patient with central retinal vein occlusion.
Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Female; Ganciclovir; Humans; Immunosuppressive Agents; Injections; Macular Edema; Polymerase Chain Reaction; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2008 |
Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.
Topics: Electroretinography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vision Disorders; Vitreous Body | 2009 |
Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Macular Edema; Phacoemulsification; Pseudophakia; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macula Lutea; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Topics: Aged; Chronic Disease; Diabetic Retinopathy; Eyeglasses; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Vitreous Body | 2008 |
Intravitreal triamcinolone.
Topics: Cataract; Disease Progression; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2008 |
Intravitreal injection of triamcinolone acetonide and intraocular pressure.
Topics: Balloon Occlusion; Equipment Design; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Monitoring, Intraoperative; Retinal Vein Occlusion; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2008 |
A new look at an old treatment for diabetic macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Prognosis; Randomized Controlled Trials as Topic; Triamcinolone Acetonide; Visual Acuity | 2008 |
Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.
Topics: Choroid Diseases; Disease Progression; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Diseases; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2008 |
Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Telangiectasis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Efficacy of sub-Tenon's capsule injection of triamcinolone acetonide for refractory diabetic macular edema after vitrectomy.
Topics: Aged; Conjunctiva; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2008 |
Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Confidence Intervals; Dexamethasone; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; False Positive Reactions; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Predictive Value of Tests; Prospective Studies; Retinal Vein Occlusion; Sensitivity and Specificity; Telangiectasis; Triamcinolone Acetonide | 2009 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Recurrence; Retina; Sulfonamides; Thiazines; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2009 |
Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Epiretinal Membrane; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Postoperative Period; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Topics: Aged; Chondroitin Sulfates; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Hyaluronic Acid; Infusions, Parenteral; Macular Edema; Male; Middle Aged; Prospective Studies; Sclera; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2009 |
Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Disease Models, Animal; Down-Regulation; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Glucocorticoids; Injections; Macular Edema; Membrane Proteins; Occludin; Ophthalmoscopy; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2009 |
Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
Topics: Aged; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fasting; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Insulin; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide | 2009 |
Explantation of intraocular lenses in children with juvenile idiopathic arthritis-associated uveitis.
Topics: Arthritis, Juvenile; Cataract; Child; Device Removal; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Macular Edema; Phacoemulsification; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy | 2009 |
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
DRCR Study: outcomes in focal vs diffuse edema?
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Topics: Endophthalmitis; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
Complications and safety profile of posterior subtenon injection of triamcinolone acetonide.
Topics: Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2009 |
Argon laser trabeculoplasty for late glaucoma after intravitreal triamcinolone.
Topics: Glaucoma; Glucocorticoids; Humans; Injections; Lasers, Gas; Macular Edema; Male; Middle Aged; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2009 |
Comparison of surgical procedures for vitreous surgery in diabetic macular edema.
Topics: Basement Membrane; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Intraoperative Complications; Macular Edema; Male; Middle Aged; Postoperative Complications; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
Intravitreal triamcinolone acetonide injection at the time of pars plana vitrectomy for retained lens material.
Topics: Aged; Cataract Extraction; Device Removal; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraoperative Care; Lens Subluxation; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Reoperation; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure.
Topics: Age Factors; Aged; Conjunctiva; Diabetic Retinopathy; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2009 |
Bilateral simultaneous intravitreal injections in the office setting.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Functional Laterality; Humans; Injections; Intraoperative Complications; Macular Degeneration; Macular Edema; Office Visits; Postoperative Complications; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection.
Topics: Acyclovir; Aged; Antiviral Agents; Epithelium, Corneal; Fascia; Female; Glucocorticoids; Herpesvirus 1, Human; Humans; Injections; Keratitis, Herpetic; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Virus Activation | 2009 |
Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Vitreous Body | 2010 |
Triamcinolone-assisted removal of internal limiting membrane enhances the effect of vitrectomy for diabetic macular edema.
Topics: Aged; Anti-Inflammatory Agents; Coloring Agents; Diabetes Complications; Female; Humans; Indocyanine Green; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2009 |
Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Topics: Cataract; Chronic Disease; Drug Administration Routes; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Orbit; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Recurrence; Retinal Perforations; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2009 |
Diabetic macular edema.
Topics: Cataract; Cataract Extraction; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Randomized Controlled Trials as Topic; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Selective laser trabeculoplasty for the treatment of intraocular pressure elevation after intravitreal triamcinolone injection.
Topics: Adult; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Ocular Hypertension; Trabeculectomy; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Correspondence.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body; Vitreous Detachment | 2009 |
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Treatment of chronic uveitic cystoid macular oedema.
Topics: Chronic Disease; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2009 |
Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
Topics: Cataract; Chronic Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Anterior staphyloma following an intravitreal injection of triamcinolone for the treatment of diabetic macular edema.
Topics: Aged; Anterior Eye Segment; Diabetic Retinopathy; Dilatation, Pathologic; Fascia Lata; Female; Glucocorticoids; Humans; Injections; Macular Edema; Microscopy, Acoustic; Scleral Diseases; Triamcinolone Acetonide; Vitreous Body | 2009 |
Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2010 |
Diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion--a matched-pairs analysis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Matched-Pair Analysis; Middle Aged; Retina; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
SCOREing in retinal venous occlusive disease.
Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
Sub-Tenon's injection of triamcinolone for optic disc neovascularization in a patient with retinitis pigmentosa.
Topics: Connective Tissue; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Optic Disk; Retinal Neovascularization; Retinitis Pigmentosa; Triamcinolone Acetonide; Visual Acuity; Young Adult | 2009 |
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2009 |
Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Administration Schedule; Drug Combinations; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2010 |
Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
[Efficacy and safety of intravitreal injection of triamcinolone acetonide as treatment for diffuse diabetic macular edema].
Topics: Diabetic Retinopathy; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Vitreous Body | 2009 |
Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide.
Topics: Drug Evaluation, Preclinical; Eye Diseases; Humans; Intraocular Pressure; Macular Edema; Meta-Analysis as Topic; Preservatives, Pharmaceutical; Triamcinolone; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2009 |
Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.
Topics: Adult; Aged; Causality; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Herpes Zoster Ophthalmicus; HIV Infections; Humans; Incidence; Injections; Macular Edema; Male; Middle Aged; Ovarian Neoplasms; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Toxic vitreitis outbreak after intravitreal injection.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Disease Outbreaks; Eye Diseases; Female; Humans; Injections; Macular Degeneration; Macular Edema; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Suppuration; Syringes; Triamcinolone Acetonide; Vitreous Body | 2010 |
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema.
Topics: Diabetic Retinopathy; Emulsions; Female; Fluprednisolone; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intraocular; Kaplan-Meier Estimate; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Secondary Prevention; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Connective Tissue; Decompression, Surgical; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Retinal Artery; Retinal Neovascularization; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chi-Square Distribution; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Tonometry, Ocular; Triamcinolone Acetonide | 2010 |
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research.
Topics: Biomedical Research; Data Interpretation, Statistical; Diagnostic Techniques, Ophthalmological; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2010 |
Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Matched-Pair Analysis; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Pseudohypopyon following intravitreal triamcinolone acetonide injection in a phakic eye.
Topics: Aged; Anti-Inflammatory Agents; Choroiditis; Diagnosis, Differential; Eye Diseases; Female; Humans; Injections; Lens, Crystalline; Macular Edema; Panuveitis; Recurrence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Chemokine CCL2; Chemokine CCL4; Chemokines; Female; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2012 |
Simultaneous intravitreal injection of triamcinolone acetonide and tissue plasminogen activator for central retinal vein occlusion: a pilot study.
Topics: Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
A new approach to the management of diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Bevacizumab and triamcinolone for branch vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2010 |
[Triamcinolone acetonide bevacizumab performance in treatment and idiopathic macular spider veins].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Triamcinolone-associated crystalline maculopathy.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
[Endophthalmitis following intravitreal triamcinolone acetonid injection--a case report].
Topics: Diabetic Retinopathy; Endophthalmitis; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Middle Aged; Staphylococcal Infections; Staphylococcus epidermidis; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields | 2011 |
Toxic anterior segment syndrome presenting as isolated cystoid macular edema after removal of entrapped ophthalmic ointment.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Female; Fluorescein Angiography; Humans; Inflammation; Macula Lutea; Macular Edema; Ointments; Phacoemulsification; Postoperative Complications; Retinal Diseases; Triamcinolone Acetonide | 2010 |
Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Exudates and Transudates; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Microscopy, Confocal; Middle Aged; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2010 |
Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Topics: Aged; Female; Fixation, Ocular; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields; Vitreous Body | 2010 |
[Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
Topics: Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Injections, Intraocular; Laser Coagulation; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion.
Topics: Administration, Intravesical; Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Behcet Syndrome; Bevacizumab; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2011 |
Early serous macular detachment after phacoemulsification surgery.
Topics: Acetazolamide; Cefuroxime; Female; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Retinal Detachment; Subretinal Fluid; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2010 |
Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Macula Lutea; Macular Edema; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Photoreceptor Cell Inner Segment; Retinal Photoreceptor Cell Outer Segment; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
[Clinical observation on treating diabetic macular edema with intravitreal triamcinolone acetonide and laser].
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Hemorrhage; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Electroretinography; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Ophthalmoscopy; Retina; Retinal Telangiectasis; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests | 2011 |
[Case of systemic lupus erythematosus showing visual disturbances resulting from multiple ocular complications].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Diagnostic Techniques, Ophthalmological; Female; Humans; Lupus Erythematosus, Systemic; Macular Edema; Magnetic Resonance Imaging; Methylprednisolone; Optic Neuropathy, Ischemic; Platelet Aggregation Inhibitors; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders | 2011 |
Enhanced oxygen saturation in optic nerve head of non-human primate eyes following the intravitreal injection of NCX 434, an innovative nitric oxide-donating glucocorticoid.
Topics: Animals; Aorta; Dexamethasone; Diabetic Retinopathy; Intraocular Pressure; Intravitreal Injections; Macaca fascicularis; Macular Edema; Male; Nitrates; Nitric Oxide Donors; Optic Disk; Oxygen; Rabbits; Triamcinolone Acetonide | 2011 |
Early macular thickening versus pseudophakic cystoid macular edema.
Topics: Acetazolamide; Cefuroxime; Fluorescein Angiography; Humans; Macular Edema; Phacoemulsification; Postoperative Complications; Recurrence; Retinal Detachment; Subretinal Fluid; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2011 |
Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Case-Control Studies; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Effects of intravitreal triamcinolone acetonide on retinal gene expression in a rat model of central retinal vein occlusion.
Topics: Animals; Cytokines; Disease Models, Animal; Gene Expression Regulation; Glucocorticoids; Intercellular Signaling Peptides and Proteins; Intravitreal Injections; Ion Channels; Macular Edema; Rats; Rats, Inbred BN; Retina; Retinal Pigment Epithelium; Retinal Vein Occlusion; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone Acetonide | 2011 |
Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.
Topics: Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Edema; Male; Retina; Triamcinolone Acetonide; Visual Acuity | 2012 |
[Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Photochemotherapy; Pigment Epithelium of Eye; Retinal Detachment; Retinal Hemorrhage; Retinal Perforations; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Hemorrhage; Wet Macular Degeneration | 2011 |
Macular infarction after inadvertent intracameral cefuroxime.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infarction; Intravitreal Injections; Macular Edema; Medication Errors; Retinal Diseases; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2011 |
Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2011 |
[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Topics: Aged; Anti-Inflammatory Agents; Diagnostic Techniques, Ophthalmological; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmoscopy; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide | 2011 |
Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Cytokines; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity | 2011 |
Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Catheterization; Diabetic Retinopathy; Exudates and Transudates; Feasibility Studies; Female; Follow-Up Studies; Humans; Macular Edema; Male; Microsurgery; Middle Aged; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity | 2012 |
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
[Evaluation of possible prognostic factors for the course of visual acuity after intravitreal ttriamconolone acetonide].
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prognosis; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Association between photoreceptor integrity and visual outcome in diabetic macular edema.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Photoreceptor Cells, Vertebrate; Prognosis; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2012 |
Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Laser Coagulation; Macular Edema; Middle Aged; Retina; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
[Complications of intravitreal injections--own experience].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 2011 |
Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema.
Topics: Cataract; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Recurrence; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2012 |
Correlation of macular thickness and posterior hyaloid change following bevacizumab and triamcinolone in diffuse diabetic macular edema in middle-aged patients.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Detachment | 2011 |
Intraocular ophthalmic ointment following anterior segment surgery.
Topics: Aged; Anterior Eye Segment; Drug Therapy, Combination; Eye Foreign Bodies; Gonioscopy; Humans; Lens Implantation, Intraocular; Macular Edema; Magnetic Resonance Spectroscopy; Male; Ointments; Petrolatum; Phacoemulsification; Prednisolone; Triamcinolone Acetonide; Vision Disorders | 2011 |
[Intravitreal triamcinolone acetonide use in diffuse persistent diabetic macular edema].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Intravitreal Injections; Longitudinal Studies; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide | 2011 |
Ocular decompression retinopathy following post-trabeculectomy suture lysis and management with triamcinolone acetonide.
Topics: Aged, 80 and over; Cataract Extraction; Chronic Disease; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Ocular Hypotension; Phacoemulsification; Postoperative Complications; Retinal Hemorrhage; Suture Techniques; Tomography, Optical Coherence; Trabeculectomy; Triamcinolone Acetonide; Visual Acuity | 2011 |
Nine-month results of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular oedema: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Glycated Hemoglobin; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
An increase in intraocular pressure after intravitreal steroid injection facilitates reduction of macular edema.
Topics: Aged; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Triamcinolone Acetonide; Visual Acuity | 2012 |
Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2012 |
Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane.
Topics: Basement Membrane; Combined Modality Therapy; Epiretinal Membrane; Female; Glucocorticoids; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2012 |
Possible short-term changes of aqueous inflammatory cytokines after intravitreal bevacizumab for diabetic macular edema.
Topics: Antibodies, Monoclonal, Humanized; Aqueous Humor; Cytokines; Diabetic Retinopathy; Female; Humans; Macular Edema; Male; Triamcinolone Acetonide | 2012 |
Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Laser Coagulation; Macula Lutea; Macular Edema; Male; Melanoma; Middle Aged; Pilot Projects; Radiation Injuries; Radiotherapy Dosage; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveal Neoplasms | 2012 |
Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Diabetic Retinopathy; Endophthalmitis; Female; Fluoroquinolones; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Long-term follow-up of inflammatory cystoid macular edema.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Macular Edema; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Prednisolone; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis, Anterior; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Young Adult | 2012 |
Quantitative analysis of cystoid macular edema using scanning laser ophthalmoscope in modified dark-field imaging.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Fluorescein Angiography; Glucocorticoids; Humans; Laser Coagulation; Lasers; Macular Edema; Middle Aged; Ophthalmoscopes; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2012 |
“Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema”.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorticoids; Humans; Macular Edema; Male; Triamcinolone Acetonide | 2012 |
Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cost-Benefit Analysis; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Markov Chains; Middle Aged; Monte Carlo Method; Ranibizumab; Triamcinolone Acetonide; Visual Acuity | 2012 |
[Intravitreal triamcinolone acetonide treatment in diabetic macular edema].
Topics: Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Postoperative Care; Preoperative Care; Prospective Studies; Risk Assessment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2011 |
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Prospective Studies; Recurrence; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields | 2012 |
Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.
Topics: Aged; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Prospective Studies; Retinal Detachment; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2012 |
[Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Failure; Triamcinolone Acetonide | 2012 |
Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
Topics: Aged; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Pseudophakia; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2012 |
Different dosages of intravitreal triamcinolone acetonide injections for macular edema secondary to central retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2012 |
Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion.
Topics: Aged; Aqueous Humor; Eye Proteins; Female; Glucocorticoids; Humans; Inflammation; Intercellular Adhesion Molecule-1; Intravitreal Injections; Macular Edema; Male; Nerve Growth Factors; Retinal Vein Occlusion; Serpins; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2013 |
Clinical applications of cost analysis of diabetic macular edema treatments.
Topics: Aged; Angiogenesis Inhibitors; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetic Retinopathy; Health Care Costs; Humans; Laser Coagulation; Macular Edema; Middle Aged; Quality-Adjusted Life Years; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Diabetic macular edema.
Topics: Angiogenesis Inhibitors; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide | 2012 |
Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2011 |
Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Administration Schedule; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 2013 |
Clinical outcomes of triamcinolone-assisted anterior vitrectomy after phacoemulsification complicated by posterior capsule rupture.
Topics: Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Phacoemulsification; Posterior Capsular Rupture, Ocular; Refraction, Ocular; Retrospective Studies; Staining and Labeling; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2013 |
Posterior vitreous detachment following intravitreal drug injection.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Follow-Up Studies; Fourier Analysis; Humans; Incidence; Intravitreal Injections; Macular Edema; Male; Microscopy, Acoustic; Middle Aged; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Detachment; Wet Macular Degeneration | 2013 |
[Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].
Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.
Topics: Aged; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Topics: Aged; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2002 |
Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.
Topics: Adrenal Cortex Hormones; Aged; Female; Fluorescein Angiography; Humans; Injections; Macular Edema; Male; Ophthalmoscopy; Pseudophakia; Retreatment; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone for refractory pseudophakic macular edema.
Topics: Aged; Cataract Extraction; Chronic Disease; Female; Glucocorticoids; Humans; Injections; Interferometry; Light; Macular Edema; Male; Middle Aged; Prospective Studies; Pseudophakia; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone.
Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Bacterial; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Female; Fluorescein Angiography; Glucocorticoids; Half-Life; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
[Steroid therapy of oedematous and neovascular eye diseases].
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Injections; Iris; Macular Edema; Neovascularization, Pathologic; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body | 2003 |
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Humans; Injections; Interferometry; Macular Edema; Male; Retinal Vein Occlusion; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema.
Topics: Aged; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Phacoemulsification; Prospective Studies; Pseudophakia; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Pseudophakia; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Interferometry; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Humans; Injections; Interferometry; Macular Edema; Male; Retinal Vein Occlusion; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema.
Topics: Female; Glucocorticoids; Humans; Injections; Interferometry; Light; Macular Edema; Middle Aged; Recurrence; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone for radiation-induced macular edema.
Topics: Fluorescein Angiography; Glucocorticoids; Humans; Injections; Interferometry; Intraocular Pressure; Light; Macular Edema; Male; Middle Aged; Parotid Neoplasms; Radiation Injuries; Retina; Tomography; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Pain; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Triamcinolone Acetonide; Vision Disorders; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema.
Topics: Aged; Chronic Disease; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Pseudophakia; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Macular hole closure after peribulbar steroid injection.
Topics: Female; Glucocorticoids; HLA-B27 Antigen; Humans; Injections; Macular Edema; Middle Aged; Orbit; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis, Anterior; Visual Acuity | 2003 |
Dosage of intravitreal triamcinolone.
Topics: Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
Topics: Adult; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vein Occlusion; Triamcinolone Acetonide | 2004 |
Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema.
Topics: Adult; Aged; Connective Tissue; Diabetic Retinopathy; Glucocorticoids; Humans; Infusions, Parenteral; Lens Implantation, Intraocular; Macular Edema; Middle Aged; Ophthalmic Solutions; Orbit; Phacoemulsification; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2004 |
Intraocular availability of triamcinolone acetonide after intravitreal injection.
Topics: Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Topics: Glucocorticoids; Humans; Injections; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Topics: Aged; Case-Control Studies; Diabetic Retinopathy; Eye Diseases; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Detachment; Retinal Vein Occlusion; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
[Intravitreal injection of triamcinolone acetonide for cystoid macular edema resistant to vitreous surgery].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Injections, Intralesional; Macular Edema; Male; Middle Aged; Postoperative Period; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion.
Topics: Adult; Aged; Child; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2004 |
Cataract surgery after intravitreal injection of triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Degeneration; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Triamcinolone Acetonide; Visual Acuity | 2004 |
Orbital abscess following subtenon triamcinolone injection.
Topics: Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clindamycin; Drainage; Eye Infections, Bacterial; Fascia; Female; Glucocorticoids; Humans; Injections; Macular Edema; Orbital Diseases; Retinal Vein Occlusion; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Triamcinolone Acetonide | 2004 |
Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Prospective Studies; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2004 |
Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report.
Topics: Adult; Anti-Inflammatory Agents; Humans; Injections; Macular Edema; Male; Retinitis Pigmentosa; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2003 |
Serum levels of triamcinolone acetonide after intravitreal injection.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Vitreous Body | 2004 |
[White planar deposits on the retina].
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Macula Lutea; Macular Edema; Middle Aged; Optic Disk; Retina; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide injection in ocular ischemic syndrome.
Topics: Aged; Eye; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ischemia; Macular Edema; Syndrome; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal injection of triamcinolone acetonide for diabetic macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Safety and efficacy of intravitreal triamcinolone.
Topics: Diabetic Retinopathy; Humans; Injections; Macular Edema; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal injection of triamcinolone for diffuse macular edema.
Topics: Biological Availability; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Preservatives, Pharmaceutical; Triamcinolone Acetonide; Vitreous Body | 2004 |
Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide.
Topics: Diabetic Retinopathy; Female; Humans; Injections; Macular Edema; Middle Aged; Ocular Hypertension; Pseudophakia; Remission Induction; Sclera; Triamcinolone Acetonide; Visual Acuity | 2004 |
Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.
Topics: Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Topics: Adult; Behcet Syndrome; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Safety; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.
Topics: Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Optic Disk; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Recurrence; Retinal Vein Occlusion; Retrospective Studies; Safety; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Exudates and Transudates; Female; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Regression Analysis; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2004 |
Intravitreal triamcinolone acetonide in Eales' disease: a case report.
Topics: Adult; Anti-Inflammatory Agents; Humans; Injections; Macular Edema; Male; Triamcinolone Acetonide; Vitreous Body | 2005 |
Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Topics: Anti-Inflammatory Agents; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Pilot Projects; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Eye Diseases; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Remission, Spontaneous; Retrospective Studies; Trabecular Meshwork; Triamcinolone Acetonide; Vitreous Body | 2004 |
Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Diabetic Retinopathy; Epidemiologic Methods; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2005 |
Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema.
Topics: Adult; Aged; Diabetic Retinopathy; Glucocorticoids; Half-Life; Humans; Injections; Macula Lutea; Macular Edema; Middle Aged; Models, Biological; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2004 |
Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Topics: Drainage; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
Diffuse intraocular dispersion of triamcinolone particles as a cause of sterile endophthalmitis.
Topics: Diffusion; Endophthalmitis; Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide | 2004 |
Acute intractable glaucoma after a single low-dose sub-Tenon's corticosteroid injection for macular edema.
Topics: Acute Disease; Aged; Connective Tissue; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Trabeculectomy; Triamcinolone Acetonide | 2004 |
Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study.
Topics: Aged; Aged, 80 and over; Asian People; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Longitudinal Studies; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Retina; Safety; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Reading; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2005 |
Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Connective Tissue; Female; Glucocorticoids; Humans; Infusions, Parenteral; Macular Edema; Middle Aged; Orbit; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2004 |
The effect of intravitreal triamcinolone on diabetic macular oedema.
Topics: Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
Topics: Aged; Blood-Retinal Barrier; Capillary Permeability; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Diabetic Retinopathy; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2004 |
Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Schedule; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity | 2005 |
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Topics: Animals; Anti-Inflammatory Agents; Blood-Aqueous Barrier; Blood-Retinal Barrier; Calcium; Dexamethasone; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Macular Edema; Rabbits; Recombinant Proteins; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2005 |
Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Quinoxalines; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.
Topics: Clinical Trials as Topic; Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2005 |
Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Pseudophakia; Retrospective Studies; Safety; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Topics: Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
Topics: Blood; Cataract Extraction; Choroid Diseases; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Lens Implantation, Intraocular; Macular Edema; Middle Aged; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2005 |
Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide.
Topics: Aged; Glucocorticoids; Humans; Macular Edema; Male; Retinal Vessels; Syndrome; Telangiectasis; Tomography, Optical Coherence; Triamcinolone Acetonide | 2006 |
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Topics: Aged; Connective Tissue; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2005 |
Intravitreal triamcinolone acetonide and secondary ocular hypertension.
Topics: Aged; Antihypertensive Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
A case of POEMS syndrome with cystoid macular edema.
Topics: Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Edema; Middle Aged; POEMS Syndrome; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy | 2005 |
Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinitis Pigmentosa; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreous triamcinolone simulating frosted retinal angiitis.
Topics: Aged; Diagnosis, Differential; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Retinal Vasculitis; Retinal Vein Occlusion; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body | 2005 |
Submacular placoid pigment epithelial alteration after resolution of macular edema in central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Decompression, Surgical; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Optic Nerve; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2005 |
Steroids for branch retinal vein occlusion.
Topics: Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2005 |
The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.
Topics: Aged; Cataract; Combined Modality Therapy; Diabetic Retinopathy; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2005 |
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Vitreous Body | 2005 |
A standardized method for reporting changes in macular thickening using optical coherence tomography.
Topics: Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Follow-Up Studies; Glucocorticoids; Humans; Macular Edema; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2005 |
Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Orbit; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Hemorrhage | 2005 |
Intravitreal triamcinolone therapy for diabetic macular oedema.
Topics: Diabetic Retinopathy; Dose-Response Relationship, Drug; Drug Administration Schedule; Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide | 2005 |
Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a three-year period.
Topics: Adult; Choroid Diseases; Chronic Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Retinal Diseases; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2005 |
Efficacy of periocular corticosteroid injections in the management of posterior uveitis.
Topics: Clinical Trials as Topic; Eye Diseases; Glucocorticoids; Humans; Injections; Macular Edema; Methylprednisolone; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Vitreous Body | 2005 |
Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2006 |
Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Topics: Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy.
Topics: Aged; Aged, 80 and over; Connective Tissue; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Orbit; Prospective Studies; Retinal Vein Occlusion; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2005 |
Intravitreal triamcinolone acetonide for refractory diabetic macular oedema.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Humans; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide | 2005 |
Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy.
Topics: Diabetic Retinopathy; Eye Diseases; Female; Glucocorticoids; Humans; Macular Edema; Male; Retina; Tissue Adhesions; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2005 |
Complications of intravitreal steroid injections.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Choroidal Neovascularization; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Ocular Hypertension; Photochemotherapy; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Outcome of intravitreal triamcinolone in uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Chronic Disease; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prednisolone; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Vitreous Hemorrhage | 2005 |
Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Topics: Aged; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Pilot Projects; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
Topics: Adult; Anesthesia, Local; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone in two patients with refractory macular oedema in sarcoid uveitis.
Topics: Aged; Female; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Recurrence; Retreatment; Sarcoidosis; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis, Posterior; Vitreous Body | 2005 |
[Intravitreal injection of triamcinolone acetonide for the treatment of macular edema].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2005 |
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation.
Topics: Blood Circulation; Blood Flow Velocity; Choroid; Connective Tissue; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Retinal Vessels; Triamcinolone Acetonide | 2005 |
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Topics: Connective Tissue; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2005 |
Resolution of cystoid macular oedema after retinal detachment repair: is intravitreal triamcinolone useful?
Topics: Aged; Glucocorticoids; Humans; Macular Edema; Male; Postoperative Complications; Retinal Detachment; Triamcinolone Acetonide | 2006 |
Decreased venous tortuosity associated with resolution of macular edema after intravitreal injection of triamcinolone.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide for persisting cystoid macular edema after penetrating keratoplasty.
Topics: Adult; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Glucocorticoids; Humans; Injections; Keratoconus; Keratoplasty, Penetrating; Macular Edema; Postoperative Complications; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient.
Topics: Aged; Cytomegalovirus; Cytomegalovirus Retinitis; Diabetic Retinopathy; DNA, Viral; Ganciclovir; Glucocorticoids; Humans; Immunocompromised Host; Injections; Macular Edema; Male; Polymerase Chain Reaction; Recurrence; Triamcinolone Acetonide; Valganciclovir; Vitreous Body | 2005 |
Intravitreal versus retrobulbar injection of triamcinolone for young patients.
Topics: Adult; Age Factors; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Orbit; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Retinal pigment epithelium (RPE) pigmentation and thickening in the central macula after macular edema resolution in central retinal vein occlusion (CRVO).
Topics: Combined Modality Therapy; Decompression, Surgical; Humans; Macula Lutea; Macular Edema; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2006 |
Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone.
Topics: Adult; Aged; Antihypertensive Agents; Glaucoma, Open-Angle; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2006 |
Subjective visual sensation during vitrectomy under retrobulbar anesthesia.
Topics: Anesthesia, Local; Epiretinal Membrane; Humans; Macular Edema; Male; Medical Illustration; Middle Aged; Orbit; Triamcinolone Acetonide; Vision, Entoptic; Visual Perception; Vitrectomy | 2006 |
Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Topics: Adult; Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Basement Membrane; Case-Control Studies; Combined Modality Therapy; Diabetic Retinopathy; Epiretinal Membrane; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prognosis; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2006 |
Intravitreal triamcinolone acetonide in Eales disease.
Topics: Adult; Eye Diseases; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Vasculitis; Triamcinolone Acetonide; Vitreous Body | 2006 |
Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
Topics: Adult; Antihypertensive Agents; Diabetic Retinopathy; Fluorescein Angiography; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Retrospective Studies; Triamcinolone Acetonide; Vision Disorders; Visual Fields; Vitreous Body | 2006 |
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Topics: Aged; Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Necrosis Syndrome, Acute; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retreatment; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.
Topics: Aged; Anti-Inflammatory Agents; Eye; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Photography; Prospective Studies; Pseudophakia; Survival Analysis; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Vitreous Body | 2006 |
Cataract formation and other complications of intravitreal triamcinolone for macular edema.
Topics: Aged; Cataract; Disease Progression; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens, Crystalline; Macular Edema; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retina; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for the treatment of diffuse diabetic macular oedema--a case report.
Topics: Adult; Diabetic Retinopathy; Glucocorticoids; Humans; Injections, Intralesional; Macular Edema; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2006 |
Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Recurrence; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide.
Topics: Abscess; Antifungal Agents; Connective Tissue; Diabetic Retinopathy; Eye Infections, Fungal; Female; Glucocorticoids; Humans; Injections; Itraconazole; Macular Edema; Middle Aged; Mycetoma; Orbital Diseases; Pseudallescheria; Tomography, X-Ray Computed; Triamcinolone Acetonide | 2007 |
Macular edema treatment.
Topics: Combined Modality Therapy; Connective Tissue; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity?
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Paracentesis; Triamcinolone Acetonide; Vitreous Body | 2006 |
Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ischemia; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Acute syphilitic posterior placoid chorioretinitis after an intravitreal triamcinolone acetonide injection.
Topics: Acute Disease; Anti-Bacterial Agents; Chorioretinitis; Eye Infections, Bacterial; Fluorescent Treponemal Antibody-Absorption Test; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Penicillin G Benzathine; Penicillin G Procaine; Syphilis; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Psoriatic uveitis-associated cystoid macular oedema treated with intravitreal triamcinolone acetonide.
Topics: Adult; Arthritis, Psoriatic; Female; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Uveitis, Intermediate; Visual Acuity; Vitreous Body | 2006 |
Trans-zonular delivery of intravitreal triamcinolone acetonide in the management of pre-existing macular oedema during cataract surgery.
Topics: Cataract; Drug Delivery Systems; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Phacoemulsification; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Schedule; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Ocular morbidity associated with intravitreal triamcinolone acetonide.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Endophthalmitis; Exfoliation Syndrome; Eye Diseases; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Detachment; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2007 |
[Incidence and risk factors of intraocular pressure elevation after triamcinolone acetonide administration for macular disorders].
Topics: Age Factors; Aged; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Myopia; Ocular Hypertension; Risk Factors; Triamcinolone Acetonide; Vitrectomy | 2006 |
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Topics: Drug Administration Schedule; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retinal Artery Occlusion; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2006 |
The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Fovea Centralis; Humans; Macular Edema; Male; Medical Records; Microinjections; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for diabetic macula edema.
Topics: Diabetic Retinopathy; Drug Administration Schedule; Humans; Macular Edema; Microinjections; Triamcinolone Acetonide; Vitreous Body | 2006 |
Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Middle Aged; Ocular Hypertension; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Visual sensation during vitrectomy under retrobulbar anesthesia.
Topics: Anesthesia, Local; Epiretinal Membrane; Humans; Macular Edema; Medical Illustration; Orbit; Triamcinolone Acetonide; Vision, Entoptic; Visual Perception; Vitrectomy | 2006 |
Technique of administering the intravitreal injection, and the optimum dosage required to gain a therapeutic benefit.
Topics: Drug Administration Schedule; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2007 |
Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Topics: Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2006 |
Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Orbit; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Uveitis, Posterior; Vitreous Body | 2006 |
Prospective optical coherence tomographic evaluation of the efficacy of oral and posterior subtenon corticosteroids in patients with intermediate uveitis.
Topics: Administration, Oral; Administration, Topical; Adult; Betamethasone; Connective Tissue; Drug Administration Routes; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Prednisolone; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Intermediate; Visual Acuity | 2007 |
Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Vein Occlusion; Statistics as Topic; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Choroidal neovascular membrane in radiation retinopathy.
Topics: Adult; Choroidal Neovascularization; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Nasopharyngeal Neoplasms; Radiation Injuries; Retina; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone for diffuse diabetic macular oedema.
Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Schedule; Glucocorticoids; Humans; Macular Edema; Recurrence; Triamcinolone Acetonide | 2006 |
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Phacoemulsification; Retinal Artery Occlusion; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Topics: Diabetic Retinopathy; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Malignant glaucoma as a complication of intravitreal triamcinolone acetonide.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2006 |
Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.
Topics: Adolescent; Adult; Aged; Cataract; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Topics: Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Ischemia; Macular Edema; Retinal Vein Occlusion; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Evaluation; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Intravitreal triamcinolone in diabetic macular edema.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glaucoma, Open-Angle; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Deposition of triamcinolone crystals on the posterior lens capsule following prone posturing post-vitrectomy.
Topics: Crystallization; Female; Glucocorticoids; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Macular Edema; Middle Aged; Phacoemulsification; Postoperative Complications; Prone Position; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy | 2006 |
Intravitreal triamcinolone to treat refractory macular edema in a postvitrectomized eye.
Topics: Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Postoperative Complications; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
Topics: Endophthalmitis; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Retinal Necrosis Syndrome, Acute; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.
Topics: Aged; Diabetic Retinopathy; Drug Evaluation; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prognosis; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study.
Topics: Adult; Aged; Electroretinography; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Filter connected with three-way cock in remove of the vehicle in triamcinolone acetonide.
Topics: Administration, Topical; Adult; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Retinal Diseases; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2006 |
Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.
Topics: Anti-Inflammatory Agents; Delayed-Action Preparations; Diabetes Complications; Drug Evaluation; Glycolates; Humans; Injections; Lactic Acid; Macular Edema; Microspheres; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Triamcinolone Acetonide; Vitreous Body | 2006 |
Triamcinolone pseudo-cataract.
Topics: Aged; Cataract; Glucocorticoids; Humans; Injections; Lens, Crystalline; Macular Edema; Male; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
[Macular oedema and intravitreal triamcinolone injections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Follow-Up Studies; Humans; Iceland; Injections; Macular Edema; Middle Aged; Phacoemulsification; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2006 |
Evaluation of intravitreal kenalog toxicity in humans.
Topics: Adult; Aged; Dark Adaptation; Diabetic Retinopathy; Drug Evaluation; Electroretinography; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.
Topics: Adult; Behcet Syndrome; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Topics: Aged; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorophotometry; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Macular Edema; Retinal Diseases; Retinitis Pigmentosa; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion.
Topics: Aged; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Field Tests | 2007 |
Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Topics: Aged; Aged, 80 and over; Electroretinography; Female; Glucocorticoids; Humans; Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Pseudophakia; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Topics: Adult; Aged; Aged, 80 and over; Basement Membrane; Combined Modality Therapy; Diabetic Retinopathy; Epiretinal Membrane; Humans; Macular Edema; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Orbit; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?
Topics: Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Triamcinolone Acetonide | 2007 |
A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
Topics: Anti-Inflammatory Agents; Endophthalmitis; Female; Fundus Oculi; Fusarium; Humans; Injections; Intraoperative Care; Macular Edema; Middle Aged; Mycoses; Postoperative Care; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retreatment; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections.
Topics: Diabetic Retinopathy; Epiretinal Membrane; Female; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retina; Retinal Perforations; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.
Topics: Aged; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Topics: Aged; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2007 |
Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Connective Tissue; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide | 2007 |
Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Topics: Aged; Blood Flow Velocity; Diabetic Retinopathy; Diastole; Eye; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ophthalmic Artery; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Resistance; Vitreous Body | 2007 |
Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
Topics: Acridine Orange; Animals; Cell Communication; Disease Models, Animal; Endothelium, Vascular; Fluorescent Dyes; Gene Expression; Glucocorticoids; Injections; Intercellular Adhesion Molecule-1; Ischemia; Leukocytes; Macular Edema; Male; P-Selectin; Rats; Rats, Long-Evans; Retinal Diseases; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide | 2007 |
Herpes simplex keratitis after intravitreal triamcinolone acetonide.
Topics: Acyclovir; Antiviral Agents; Diabetic Retinopathy; Female; Glucocorticoids; Herpesvirus 1, Human; Humans; Injections; Keratitis, Herpetic; Macular Edema; Middle Aged; Recurrence; Triamcinolone Acetonide; Virus Activation; Vitreous Body | 2007 |
Bilateral cystoid macular edema after phacoemulsification in post-laser in situ keratomileusis eyes.
Topics: Aged; Cornea; Fluorescein Angiography; Functional Laterality; Glucocorticoids; Humans; Keratomileusis, Laser In Situ; Macular Edema; Male; Myopia; Phacoemulsification; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2007 |
[Considerations about intravitreal triamcinolone use].
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Triamcinolone Acetonide; Vitreous Body | 2007 |
Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Topics: Aged; Case-Control Studies; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration.
Topics: Adult; Aged; Aged, 80 and over; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Topics: Adult; Chemotherapy, Adjuvant; Diabetic Retinopathy; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Photochemotherapy; Pilot Projects; Retinal Diseases; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection.
Topics: Diabetic Retinopathy; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
[Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Resistance; Humans; Injections; Macular Edema; Male; Phacoemulsification; Postoperative Complications; Pseudophakia; Triamcinolone Acetonide | 2007 |
The inadvertent administration of intralenticular triamcinolone.
Topics: Cataract; Female; Glucocorticoids; Humans; Injections; Lens Capsule, Crystalline; Macular Edema; Medication Errors; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema.
Topics: Adult; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Optic Disk; Optic Nerve Diseases; Phlebitis; Retinal Vein; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
A case of herpetic keratitis after intravitreal triamcinolone injection.
Topics: Acyclovir; Aged, 80 and over; Antiviral Agents; Epithelium, Corneal; Glucocorticoids; Herpesvirus 1, Human; Humans; Injections; Keratitis, Herpetic; Macular Edema; Male; Triamcinolone Acetonide; Virus Activation; Vitreous Body | 2007 |
[Intravitreal triamcinolone acetonide injections in treatment of cystoid macular edema due to diabetic maculopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2007 |
[Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Injections; Macular Edema; Male; Middle Aged; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2007 |
Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body | 2007 |
Viscocanalostomy for refractory glaucoma secondary to intravitreal triamcinolone acetonide injection.
Topics: Aged; Female; Filtering Surgery; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Sclera; Surgical Flaps; Triamcinolone Acetonide | 2007 |
Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Topics: Aged; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Male; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Topics: Adult; Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female.
Topics: Adult; Androgen Antagonists; Female; Glucocorticoids; Hirsutism; Humans; Macular Edema; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide | 2007 |
Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cataract; Disease Progression; Drug Evaluation; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Topics: Adult; Connective Tissue; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Intermediate; Visual Acuity; Vitreous Body | 2007 |
Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.
Topics: Aged; Connective Tissue; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Intravitreal triamcinolone for macular edema in Lyme disease.
Topics: Adult; Anti-Bacterial Agents; Doxycycline; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Lyme Disease; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection.
Topics: Aged; Benzyl Alcohol; Endophthalmitis; Female; Filtration; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2008 |
[Resorption of the diabetic cystoid macular edema after intravitreal triamcinolon acetonide injection depending on compensation of diabetes and systemic hypertension].
Topics: Aged; Aged, 80 and over; Blood Pressure; Diabetic Retinopathy; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Injections; Macular Edema; Male; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2008 |
Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2008 |
Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Macular Edema; Male; Middle Aged; Postoperative Period; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2008 |
A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.
Topics: Connective Tissue; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2008 |
Myopathic ptosis following posterior sub-Tenon's triamcinolone acetonide injection.
Topics: Aged; Blepharoptosis; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Oculomotor Muscles; Triamcinolone Acetonide | 2009 |
Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation.
Topics: Animals; Cell Adhesion; Connective Tissue; Disease Models, Animal; Endothelium, Vascular; Fluorescent Antibody Technique, Indirect; Fluorophotometry; Glucocorticoids; Image Processing, Computer-Assisted; Intercellular Adhesion Molecule-1; Laser Coagulation; Leukocytes; Macular Edema; Male; Microcirculation; Rats; Rats, Inbred BN; Retina; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide | 2008 |
Intravitreal triamcinolone and blood glucose.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retinal Detachment; Triamcinolone Acetonide; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 2008 |
Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis.
Topics: Adult; Anterior Chamber; Anti-Inflammatory Agents; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Photometry; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Topics: Aged; Aged, 80 and over; Connective Tissue; Diabetic Retinopathy; Disease Progression; Female; Glucocorticoids; Humans; Incidence; Injections; Intraoperative Care; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Biochemical quantification of triamcinolone in subconjunctival depots.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Conjunctiva; Delayed-Action Preparations; Female; Glaucoma; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 1995 |
A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications.
Topics: Administration, Topical; Aged; Connective Tissue; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Orbit; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity | 1997 |
Retrobulbar versus sub-Tenon's corticosteroid therapy.
Topics: Cataract Extraction; Connective Tissue; Glucocorticoids; Humans; Injections; Macular Edema; Orbit; Retrospective Studies; Triamcinolone Acetonide | 1998 |
Retrobulbar versus sub-Tenon's corticosteroid therapy.
Topics: Cataract Extraction; Connective Tissue; Glucocorticoids; Humans; Injections; Macular Edema; Orbit; Triamcinolone Acetonide | 1998 |
Sub-tenon's corticosteroids for the treatment of macular edema in bone marrow transplant retinopathy.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Connective Tissue; Fascia; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Diseases; Triamcinolone Acetonide | 1999 |
Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Female; Glucocorticoids; HLA-B27 Antigen; Humans; Macular Edema; Male; Middle Aged; Optic Disk; Prednisolone; Triamcinolone Acetonide; Uveitis, Anterior; Vitreous Body | 1999 |
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Female; Glucocorticoids; Humans; Injections; Interferometry; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Sound; Tomography; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2001 |
Echographic localisation of corticosteroid after retrobulbar injection.
Topics: Anti-Inflammatory Agents; Drug Delivery Systems; Humans; Macular Edema; Triamcinolone Acetonide; Ultrasonography | 2001 |
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.
Topics: Aged; Chemotherapy, Adjuvant; Crystallization; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2001 |
Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.
Topics: Adult; Chorioretinitis; Female; Glucocorticoids; HLA-A Antigens; Humans; Injections; Macular Edema; Middle Aged; Tomography; Triamcinolone Acetonide; Vitreous Body | 2001 |
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Macular Edema; Retinal Vein Occlusion; Triamcinolone Acetonide | 2002 |
Cystoid macular edema following extraocular muscle surgery.
Topics: Aged; Diplopia; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Edema; Oculomotor Muscles; Postoperative Complications; Prednisolone; Strabismus; Triamcinolone Acetonide | 2002 |
Lower eyelid herniation of orbital fat may complicate periocular corticosteroid injection.
Topics: Adipose Tissue; Adult; Eyelid Diseases; Glucocorticoids; Hernia; Humans; Injections; Macular Edema; Male; Orbital Diseases; Pars Planitis; Triamcinolone Acetonide | 2002 |